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Abstract  
Studies of the kinetics and mechanisms of the dissolution and growth of crystals and 
other solids are beneficial in many areas of science. In pharmaceutical science, 
dissolution testing is a key quality control procedure used to determine the rate at 
which an active pharmaceutical ingredient (API) is released and is thus available for 
absorption in the gastro-intestinal tract. However, the general processes governing 
the dissolution and growth of crystals are poorly understood despite many years of 
study. This thesis focuses on the implementation of various microscopy and 
electrochemical techniques as a novel approach to further understand the dissolution 
and growth of API crystals and amorphous solids. The motive of the first part of the 
thesis, was the use of atomic force microscopy (AFM) to obtain new insight into API 
dissolution and growth from both the crystalline form and amorphous solid state. 
Studies of the crystalline API, bicalutamide have focused on measuring the 3D 
morphological changes of individual microcrystals in aqueous solution, in real time, 
from which the intrinsic dissolution rates of each crystal surface exposed to solution 
have been extracted. In addition, with finite element method (FEM) modelling, 
interfacial concentrations around the dissolving crystal have been obtained, allowing 
the elucidation of the kinetic regime of the overall dissolution reaction. A major 
conclusion of this work is that the dissolution kinetics accelerate significantly during 
the process, due to changes in nanoscale features on the surface. AFM was then used 
to examine targeted regions of dissolving amorphous solid dispersions (ASDs), 
comprising of felodipine API and the water-soluble polymer copovidone, in aqueous 
solution, together with a localized electrochemical-droplet (flux measuring) technique 
and Raman spectroscopy. This multi-microscopy approach allowed real-time 
information about initial API release rates, and changes in solid-state composition and 
morphology during dissolution. This thesis then transitions to the study of 
nanocrystallization of APIs using nanopipettes under electrochemical control in a 
nanoscale anti-solvent configuration using bicalutamide, as an example system. A key 
feature of the technique is that a bias between an electrode in the nanopipette, and 
one in bulk solution, can be used to control the supersaturation level at the end of the 
nanopipette and the current-time response detects nucleation and growth events. 
Using Raman microscopy the formation of the least stable crystal polymorph of Form 
II was demonstrated. To highlight the generality of nanopipette-based electrochemical 
techniques, a final results chapter reports the use of scanning electrochemical cell 
microscopy (SECCM) to study the electro-oxidation of nicotinamide adenine 
dinucleotide (NADH), on various carbon electrodes, showing how active surface sites 
are readily identified and quantified. 
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Chapter 1  
Introduction 
_____________________________________ 
The development of pharmaceutical compounds with important therapeutic benefits is 
of considerable importance. Unfortunately, many active pharmaceutical ingredients 
(APIs) that enter the pharmaceutical pipeline lack the desired characteristics for 
maximum in vivo performance, which is governed in part by dissolution of the API 
from a crystalline or other solid form. This chapter introduces the basic concepts of 
crystal dissolution and shows the importance of fundamental understanding of both 
crystal growth and dissolution. In addition, this chapter highlights and discusses 
general methods used to provide better aqueous solubility and bioavailability of 
pharmaceutical drugs. This chapter gives an overview of scanning probe microscopy 
techniques and how they can be implemented in the study of dissolution and growth of 
crystals which is a major focus of the work herein. Finally, a brief summary of the 
work undertaken in this thesis is provided.    
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1.1. Crystal Dissolution  
Various areas of science and a number of industries require a fundamental 
understanding of crystal dissolution. Focusing on the pharmaceutical domain, 
dissolution testing is a key quality control procedure used to determine the rate at 
which a crystalline drug product releases an active pharmaceutical ingredient (API) in 
a suitable fashion, such that the API is released from the tablet into solution, and is 
available for absorption in the gastrointestinal tract.  
However, before any absorption can take place at all, a significant property to 
address is solubility.1 Solubility is the concentration of solute in a saturated solution 
at a defined temperature and pressure.2  If a drug exhibits very low solubility in 
water, only small amounts of the drug will be available for diffusion and permeate 
across the various barriers in the living organism to reach the site of action. Hence, 
solubility is considered as the limiting factor in the absorption process of a poorly 
water soluble API and have been reported in many cases.3-8 This has led to the 
implementation of solubility screens in the early stages of drug design. It is 
estimated that ~40% or more of the new pharmaceutical products developed 
through drug discovery companies are poorly water soluble.9,10 
Together with the intestinal permeability (i.e. molecules must penetrate the 
biological membrane to be absorbed), the solubility behavior of an API is a key 
factor of its oral bioavailability.11,12 Thus, because of the importance of interplay 
between the two in biopharmaceutics of products, API candidates are classified by 
using the biopharmaceutics classification system (BCS) devised by Amidon et al in 
199513 (illustrated in Figure 1.1). As shown, the system defines APIs as a 
combination of solubility and permeability. APIs are highly soluble when the 
highest dose strength is soluble in 250 ml or less of aqueous media across the 
physiological pH range (1-7.5).2,14 Whereas, APIs that are insoluble in these 
conditions are considered to have low solubility.2 Putting such system into 
application provides several benefits, including shortened drug product 
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development time and large cost savings. While the BCS provides vital information 
on the solubility and permeation characteristics of a drug, the intrinsic dissolution 
rate (IDR) is an important concept that further characterizes solution concentration 
of a drug.15-18 In pharmaceutical sciences, IDR is defined as the dissolution rate of 
a pure drug compound under the condition of constant surface area, agitation or 
stirring speed, ionic strength and pH of the dissolution medium. It is generally 
expressed as the mass of solute appearing in the dissolution medium per unit time, 
also known as dissolution flux (as the rate is normalized by surface area). 
Accordingly, it allows the study of the effects of surfactants and pH on the 
solubilization of poorly soluble drugs which can result in better correlation with in 
vivo drug dissolution rate than solubility.19  
 
 
Figure 1.1. Biopharmaceutics classification system. 
 
1.2. Solubility Improvements 
As mentioned above, solubility is a major issue in the development of marketable 
formulations of poorly water soluble drugs.20 If a drug exhibits very low solubility 
in water and / or if its dissolution rate at the site of administration is very low, 
limited amounts of drug become available for adsorption resulting in poor in vivo 
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performance. Most of the drugs are either weakly acidic or weakly basic having 
poor aqueous solubility, particularly class II drugs of the BCS system. Poor aqueous 
solubility can often be attributed to strong intermolecular forces within the crystal 
lattice.21 This will prevent molecules from escaping into solution (dissolution) and 
eventually lead to inadequate bioavailability. However this is not always the case 
when the nature of the solvent is considered. Understanding the solubility of a 
chemical compound in solvents is a key requirement for the development of a 
crystallization process. Water is able to solvate molecules and ions through dipole 
interactions, particularly hydrogen bonding allowing the compound to dissolve, e.g. 
although NaCl has strong ionic bonds within its crystal lattice it completely 
dissolves in water. This can be rationalized on the basis of solvent polarity and the 
maxim like dissolves like (a non-polar compound will be dissolved by a non-polar 
solvent and vice versa). In addition, the solubility of Ibuprofen is high in organic 
solvents such as ethanol, ethyl acetate and toluene and low in water and acetonitrile. 
Accordingly, methodologies which involve the modifications of crystal structure 
have been used to enhance solubility and increase dissolution rates.22-25 
 
1.2.1. Salt Formation 
For ionizable drugs, salt formation is the simplest and most cost-effective strategy 
to circumvent poor aqueous solubility and enhance bioavailability.26-29 About half 
of all the drug substances are administered as salts.30 Just like the formation of a 
basic salt, a drug compound, classified as a weak acid or a weak base, can be 
combined with a suitable base or acid, respectively, to form a pharmaceutical salt. 
The aqueous solubility of an acidic or basic drug as a function of pH controls 
whether the compound will form suitable salts or not. By varying the pH, the pH-
solubility profile of an acidic/basic drug can be illustrated by two curves (see Figure 
1.2), one where the saturation or equilibrium species is the free acid/base and the 
other where the salt is the equilibrium species.31 The point where the curves 
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intersect is called the pHmax.
2 This is the point where maximum solubility is 
achieved and where both the free acid/base and salt coexist as solids. Interest in the 
formation of pharmaceutical salts has increased significantly over the years with 
this technique becoming relatively common in drug product development.32  
 
Figure 1.2. Solubility versus pH. 
 
1.2.2. Pharmaceutical Cocrystals  
Briefly, for non-ionizable drugs, an alternative method to enhance solubility is to use 
cocrystalization.33-37 A lot of drugs exist in the crystalline solid state due to better 
stability and ease of handling during the different stages of drug development. The 
term crystalline, indicates an ideal crystal in which the structural units, named unit 
cells, are repeated regularly and indefinitely in three dimensions in space. A simple 
way to describe cocrystals is that they are crystalline material comprised of at least 
two molecular species held together by non-covalent interactions where all 
components are solid under ambient conditions.33,38-40 Cocrystals are an important 
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class of pharmaceutical materials that can enhance solubility and dissolution by 
forming a crystal of a drug and a conformer with specific stoichiometric compositions 
as shown in Figure 1.3. Cocrystals have the ability to effect the strength of the crystal 
lattice and the solvation of cocrystal components.41,42 Such methodology have shown 
significant attention which has led to the FDA releasing guidelines regarding 
cocrystals in 2011.43  
 
 
Figure 1.3. Representation of API cocrystal. 
 
1.2.3. Nanosizing  
A simpler drug delivery approach for poorly water-soluble drugs is reducing the API 
particle size to the submicron range.44,45 Commonly, a method that is referred to as 
micronization/nanosizing, the final particle size having a mean diameter of < 1 μm.46 
One of the earliest application of pharmaceutical nanotechnology was on danazol, an 
API that belong to class II drugs of BCS.47 Danazol milled to a median particle size of 
169 nm has resulted in enhanced oral bioavailability as compared to the regular drug. 
The essence of this approach is primarily the increase in surface area. When the particle 
size is reduced, the larger surface area of the API allows the increase in the surface 
area to volume ratio thus increasing the surface area available for solvation. 
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Consequently, it provides rapid dissolution without altering the chemical nature of the 
API. As shown by Noyes-Whitney model of dissolution (discussed vide infra) the 
surface area of the solid drug is directly proportional to its rate of dissolution. Several 
studies have been done and are reported to confirm this.48-50 Nanoparticles of poorly 
water soluble APIs can be produced by various technologies, which can be broadly 
categorized into bottom-up and the top down technologies.51 In bottom-up 
technologies controlled crystallization is achieved by dissolving the API molecule in 
a solvent, subsequently this solution is added to a non-solvent solution forming a 
supersaturated solution. Through rapid nucleation, the formation of small nuclei are 
obtained. Top-down technologies include high-pressure homogenization (in which the 
API is dispersed in solution and is forced under pressure through a nanosized aperture 
valve of a high pressure homogenizer) and milling methods.51,52 Such techniques 
provide more efficient size reduction.53 Nanoparticle technology has become a well-
established and well tested approach for poorly-soluble drugs.54 
 
1.2.4. Polymorphism 
Another method to improve solubility is to use a particular polymorphic form of drug 
molecules.55-57 Crystalline polymorphs have the same chemical composition but 
different internal crystal structure, including unit cell dimensions and crystal packing 
which can affect pharmaceutical performance.58,59 At any given combination of 
temperature, pressure and humidity, one of the crystal forms will have the lowest 
energy and thus be the preferred form with the most stable crystal lattice arrangement 
(Figure 1.4 shows a cartoon illustration). Any given two polymorphs can be either 
monotropic or enantiotropic. If one crystal form is more stable regardless of 
temperature, then the system is monotropic, Figure 1.5 (i). However, a system where 
one form is stable at higher temperatures and another form in lower temperatures is 
referred to enantiotropic system. Below the melting point, the transition temperature 
at which the free energy between two polymorphs is equal. Thus, one form is stable 
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above the transition temperature, and other form is stable below the transition 
temperature, Figure 1.5 (ii).       
 
 
Figure 1.4. Representation of structural polymorphism. 
 
 
Figure 1.5. Energy versus temperature diagram of (i) monotropic system and (ii) 
enantiotropic where Tp is the transition temperature. 
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However, a system in an unstable state does not necessarily transform directly into the 
most thermodynamically stable state, thus indicating the presence of metastable 
intermediate states, as described by Ostwald in 1897.60 According to Oswald, in 
general, the least stable polymorph crystallizes first followed by the transformation to 
the next most stable solid state until the most stable state with the minimum energy is 
achieved, see Figure 1.6. Hitherto, many have highlighted that growing crystals in 
nanoscale containers restrict their size and alignment which can influence the final 
crystal structure.61-66 The concept of crystallization at the nanoscale will be brought to 
attention in chapter 5. 
 
 
Figure 1.6. Energy states of polymorphs explaining Ostwald’s rule of stages. 
 
Many pharmaceutical drugs, despite their physical nature (i.e. being neutral, free acids, 
free bases or pharmaceutical salts), are capable of exhibiting polymorphism. Although 
some may have none, others may have multiple polymorphs. The most 
thermodynamically stable (highest density and melting point) polymorph, despite 
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having lower aqueous solubility, is most likely to be chosen for drug formulations to 
avoid any phase transitions. The first recognized example of polymorphism in a 
molecular crystal was benzamide, observed by Friedrich Wçhler and Justus von Liebig 
in 1832.67 Early pioneering reports of Aguiar et al56,57 have emphasized the impact of 
drug polymorphism on bioavailability, which numerous studies and reviews 
followed.68-73 A notable case of polymorphism is perhaps ritonavir, an antiretroviral 
medication used along with other medications to treat HIV.74 The initially developed 
form of ritonavir was found to convert to a more stable and less soluble polymorph 
resulting in a reduction in its bioavailability. The ability to control polymorphism has 
provide difficult, due to limited understanding of nucleation pathways (vide infra) and 
the absence of methods that can study crystallization at its earliest stages.   
 
1.2.5. Amorphous Solid Dispersion  
Following on, another approach shown to enhance bioavailability of APIs is to 
formulate solid dispersions.75,76 The term solid dispersion can be described as a group 
of solid products consisting of at least two different components. This brings us to the 
discussion of amorphous solid dispersions (ASDs) as an alternative way to use the 
metastable form of the API to increase the extent and rate of dissolution.25,77,78 It is 
well established that the metastable forms of drug substances enhance solubility over 
their thermodynamic stable counterparts.71,79,80 In ASD formulations, the API is in a 
metastable form, it being in an amorphous state. Here, the metastable amorphous API 
is mixed with a suitable water soluble polymer forming a molecular dispersion as 
shown in Figure 1.7. The polymer carrier improves the API’s solid-state physical 
stability reducing its molecular mobility by increasing the glass transition temperature 
of the mixture.81 Additionally, it helps to stabilize the amorphous solid form during 
storage and manufacture processes. Existing in an amorphous form results in a more 
extensive and faster dissolution as it lacks the long-range crystalline order and has 
lower packing efficiency. Thus, drug molecules do not have to overcome the crystal 
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lattice energy for it to dissolve. To maintain the amorphous state of the solid, the 
polymer interacts with the molecules of the API by attractive forces of hydrogen 
bonding.77,82 This also results in an increase in surface area of the API to increase the 
rate of dissolution (as described by Noyes-Whitney theory, discussed in section 1.4). 
In addition, due to the polymer’s large surface area it can inhibit crystallization, delay 
or prevent nucleation and growth of crystals during dissolution. Commonly used 
polymers such as hydroxypropyl methylcellulose (HPMC), Hydroxypropyl cellulose 
(HPC) and Polyvinylpyrrolidone (PVP) are biologically inert and regarded safe which 
is beneficial for reach purposes. As highlighted polymer carriers are crucial in the 
formulation of ASD, and thus the understanding of polymer-API interaction is 
necessary. Elucidating polymer interaction with amorphous solids in aqueous medium 
is a complex process which is studied by many83-90 and is further explored in chapter 
4.      
 
Figure 1.7. Representation of the composition of ASD. 
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1.3. Nucleation and Growth of Crystals  
A traditional model for the early stages of crystallization is described by two 
processes.91,92 First being nucleation for the formation of stable atomic/molecular 
clusters and secondly the subsequent growth of the nuclei that form spontaneously out 
of a supersaturated solution or undercooled melt (i.e. below its freezing point).93 In 
solution crystallization, nucleation plays a critical role in determining the crystal 
structure (hence polymorphism) and size distribution. Thus, fundamental 
understanding of nucleation is of high demand to achieve control over these properties.   
 
Firstly, in order for nucleation and growth of a crystal to occur, the concept of 
supersaturation needs to be addressed. Supersaturation is the driving force required for 
the nucleation process to proceed and it is defined as the difference in chemical 
potential between a molecule in solution and that in the bulk of the crystal phase, 
equation 1: 
 
∆𝜇 =  𝜇𝑠 − 𝜇𝑐         (𝟏) 
where 𝜇𝑠 is the chemical potential of a molecule in solution and 𝜇𝑐 is the chemical 
potential of the molecule in the bulk crystal.  
 
In thermodynamic terms, the driving force can be expressed as shown in equation 2: 
 
∆𝜇 = 𝑘𝐵𝑇 ln 𝑆        (𝟐) 
where 𝑘𝐵 is the Boltzmann constant, T is the absolute temperature, and S is the 
supersaturation ratio (solution concentration / equilibrium concentration).   
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Nucleation can either be classed as homogeneous or heterogeneous, collectively 
known as primary nucleation.94,95 The spontaneous formation and subsequent growth 
of new particles in the bulk supersaturated solution in the absence of foreign particles 
is a homogenous process. In contrast, heterogeneous nucleation occurs in the presence 
of foreign materials (e.g. particle or a surface layer), due to the complexity behavior 
of the real world, most nucleation process are in fact heterogeneous. Nucleation 
consists of a series of processes in which the atoms/molecules of a reactant phase 
rearrange into a cluster of the product phase. This formed cluster is defined as nucleus, 
i.e. minimum amount of a new phase capable of independent existence that can grow 
to a macroscopically larger size.  
Importantly, another feature of nucleation is the required passage over a free energy 
barrier for transformation to occur.96 This can be easily understood when the free 
energy changes associated with the formation of the nucleus are considered. According 
to nucleation theory, the amount of energy required to form a nucleus is the difference 
between the free energy of the system in its final and initial states as well as a term 
related to the formation of an interface between nucleus and solution. Assuming a 
spherical nucleus (as shown in Figure 1.8 (a)) this statement can be expressed by 
equation 3: 
 
∆𝐺 =  −
4
3
𝜋 ∙
𝑟3
𝑉
 ∆𝜇 + 4𝜋 ∙ 𝑟2𝛾        (𝟑) 
                                                                ∆𝐺𝑉                  ∆𝐺𝑠 
where V is the molecular volume, r is the radius of the cluster, and 𝛾 is the interfacial 
free energy between the solid and liquid phases 
This thermodynamic description was developed by Gibbs at the end of the 19th 
century.97 The free energy change required for cluster formation (∆𝐺) is the total free 
energy change for the phase transformation (Δ𝐺𝑉) and the free energy change for the 
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formation of a surface (Δ𝐺𝑆), represented in Figure 1.8 (b). Overall, the spontaneous 
growth of clusters depends on the competitive interplay between a decrease in Δ𝐺𝑉 
(which favors growth) and an increase in Δ𝐺𝑆 (which favors dissolution). At small 
radii, the positive surface free energy (Δ𝐺𝑆) is dominating, resulting in an initial 
increase in the total free energy of the system. Thus, the smallest clusters in solution 
typically dissolve. As the size of clusters increases; the total free energy goes through 
a maximum at an intermediate size, known as the critical size (r*), highlighted in 
Figure 1.8 (b). Above the critical size the total free energy deceases continuously 
making the growth step energetically favorable and resulting in the formation of crystal 
nuclei. This phenomenon is referred to as the Gibbs-Thomson effect. 98 
The significance of the critical size concept is that it determines the probability of a 
nucleus formation at any given timescale, i.e. determining the kinetics of the 
nucleation. The rate of nucleation (𝐽), which is the number of nuclei formed per unit 
time per unit volume is expressed by an Arrhenius form shown in equation 4:  
 
𝐽 = 𝐴 𝑒𝑥𝑝(−
∆𝐺𝑐𝑟𝑖𝑡𝑖𝑐𝑎𝑙
𝑘𝑇 )        (𝟒) 
where A is the pre-exponential factor and depends on the supersaturation, k is the 
Boltzmann’s constant and T is the temperature.   
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Figure 1.8. (a) Formation of a spherical nucleus of radius r. (b) Total free energy as a 
function of the radius r of the cluster. 
 
If nucleation occurs quickly, many crystals will form nearly simultaneously. The 
growth of such amount of crystals depletes solute from medium which may lead to the 
termination of the nucleation process at later stages of crystallization. As a result, 
majority of the crystals grow to similar sizes. On the other hand, if nucleation takes 
place slowly (i.e. fewer crystals nucleating at a time), the overall supersaturation of the 
solution decreases slowly, and so, nucleation of new crystals proceed, resulting in 
crystals of various sizes.99               
Overall, there has been significant interest in the understanding of crystal nucleation 
mechanisms in solution. Accordingly many advances followed such as the two-step 
mechanism in protein crystallization. Briefly, as the name suggests, two energy 
barriers must be overcome which consist of first the formation of a dense liquid 
followed by the nucleation of crystals within this dense liquid. Beside proteins, two-
step nucleation has shown to be applicable in other systems, including organic 
molecules and colloids. 99,100 
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1.4. Crystal Growth/Dissolution Reactions  
Understanding the fundamental factors which influence crystal dissolution can provide 
an insight into the dissolution behavior of drug crystals both in vitro and in vivo. As 
considerably, understanding the mechanisms that take place during the initial 
crystallization of pharmaceutical products are vital. Accordingly, the fundamental 
understanding of both processes can assist in enhancement of drug development and 
future formulation.  
Crystal dissolution is a process driven by the local undersaturation at the 
crystal/solution interface. The dissolution of a solid in fluid occurs in a series of steps 
(see Figure 1.9) which include:  
1. Detachment of species from a dissolution site, 
2. Surface diffusion of the detached species, 
3. Desorption (and adsorption), 
4. Mass transport away from the crystal i.e. movement of species into the bulk      
solution. 
 
Figure 1.9. Schematic of the elementary steps involved in dissolution processes 
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For simplicity, these processes are often encapsulated by the two terms: (A) surface 
reactions and (B) mass transport in which (A) consist of steps 1-3 and (B) involves 
step 4. The slowest of these (A or B) control the overall dissolution reaction rate. A 
reaction process in which the rate of arrival of species to the bulk solution from the 
solid surface is slow is referred to as diffusion or mass transport limited. Hence, in this 
case, equilibrium solubility is rapidly achieved at the surface. Whereas, if the transport 
rate of species away from the crystal surface is fast, the rate becomes dependent on 
surface processes. This is characterized as surface or kinetic limited reaction process. 
Here, the drug concentration near the surface is less than its solubility concentration. 
A third scenario that can be observed is when both steps (A) and (B) are occurring at 
comparable rates. Therefore, neither the interfacial step nor diffusion are dissolution 
rate limiting. Figure 1.10, shows concentration profiles under different dissolution 
modes. The mass transport-limited dissolution model was developed from early 
studies done by Noyes and Whitney in 1897.101,102  
 
 
Figure 1.10. Concentration profiles under different dissolution modes: (i) diffusion 
rate controlled; (ii) mixed rate control and (iii) reaction rate controlled dissolution. 
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Noyes and Whitney conducted the first dissolution experiments and stated that the 
dissolution rate of a solid is a linear function of the difference between its solubility 
and its bulk concentration, represented in equation 5:  
 
𝑑𝑐
𝑑𝑡
= 𝑘(𝐶𝑠 − 𝐶𝑡)        (𝟓) 
where c is the amount dissolved as a function of time (t), k is a system dependent 
constant; Cs is the solubility of the substance and Ct is the concentration of dissolved 
substance in bulk solution at time t.   
Although, Noyes and Whitney theory was seminal it failed to elucidate the physical 
meaning of the constant k. Thus, later on in 1904, Nernst and Brunner conducted 
further experiments to confirm the Noyes-Whitney equation and quantified the 
constant k.103,104 They introduced the concept of a stationary diffusion layer across 
which the solute diffuses from the solid surface to the bulk solution forming a linear 
concentration profile as illustrated in Figure 1.10 (i). They noted that k was 
proportional to the diffusion coefficient of the solid within the diffusion layer and the 
surface area of the dissolving body. Thus, equation 1 was rewritten and named the 
Nernst-Brunner equation 6:  
 
𝑑𝑐
𝑑𝑡
=  
𝑆 𝐷
𝛿
 (𝑐𝑠 − 𝑐𝑡)        (6) 
where S is the surface area, D is the diffusion coefficient and δ represents the thickness 
of the diffusion layer. 
Noyes and Whitney assumed that crystal growth was the reverse of dissolution, and 
that the rates of both processes were governed by the difference between concentration 
at the solid surface and in the bulk of the solution. If both growth and dissolution 
processes were purely diffusion controlled in nature; the rate of growth should equal 
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the rate of dissolution at a given temperature. In addition, all faces of a crystal would 
grow and dissolve at the same rate. However, these conditions are rarely achieved.105  
The dissolution of a solid crystal is further complicated when the nature of the crystal 
is considered in detail. Crystal surfaces consist of a number of features and much of 
the theoretical work on surface controlled reactions is based on the concept that 
surfaces are energetically heterogeneous.106,107 Kossel developed one of the earliest 
models in the 1930s which represented the crystal surface as cubic units containing 
layers of monoatomic height limited by steps/edges.105,108-112 Each step may comprise 
one or more kink along its length. Further, a terrace is referred to the area between 
steps and may contain vacancies or adsorbed growth units as shown in Figure 1.11. 
Dissolution starts, preferentially, at sites on the crystal surface which have excess free 
energy as it results in a reduction in the activation energy for dissolution such as 
dislocations, kinks, edges and ledges.105,108-112 Thus, one could assume that a crystal 
with higher dislocation density should have a higher thermodynamic activity and may 
result in a greater overall dissolution rate when the process is under surface control. 
Chapter 3 will further cover this concept as well as the necessity to determine the 
relative contribution of mass transport and surface reactions to understand the overall 
dissolution kinetics. 
 
Figure 1.11. Kossel model of a crystal surface. 
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A transport-controlled reaction is rate limited by transport of the dissolving species 
through the diffusion layer. The concentration gradient across the diffusion layer can 
be altered by changing the mass transport rate. An innovative way to obtain fast and 
well defined mass transport rates is to use single isolated microcrystals.113-115 “Micro-
crystal” is a term used to describe a crystal with dimensions on the micron scale and it 
is a concept which is derived from the field of electrochemistry and 
ultramicroelectrodes (UMEs) (discussed later on in section 1.6.2). If the crystal is 
much larger than this, the diffusion across the surface will be largely planar resulting 
in low and rather ill-defined diffusion rates (in stationary solution) seen in Figure 1.12 
(a). For micro-crystals, diffusion of species from all direction is possible, i.e. quasi-
hemispherical that allows fast and well-defined diffusion rates (Figure 1.12 (b)). 
 
 
Figure 1.12. (a) Macrocrystal showing predominantly planar diffusion and (b) 
microcrystal showing predominantly hemispherical diffusion. Diagrams not to scale.  
 
1.5. Traditional Dissolution Testing 
In pharmaceutical drug development process, IDRs can provide key information about 
the API with respect to constant media pH, temperature, and surface area.116 According 
to the United States Pharmacopeia (USP) critique on dissolution, the required 
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apparatus includes a vessel filled with an aqueous solution that is held at 37 °C and 
stirred at a constant rate.117-119 There are seven apparatuses in the USP general chapter 
<711>.120 The main two used for dissolution testing of solid oral dosage forms are 
Apparatus I (Basket) and Apparatus II (Paddle), shown in Figure 1.13.   
 
Figure 1.13. Illustration of dissolution Apparatus I (Basket) and II (Paddle). 
For apparatus I, the dosage form is placed in a basket fixed to the end of a spindle. 
Agitation is then introduced to the system by commonly rotating the basket at 100 
rpm121. Apparatus II uses a paddle typically rotated at 50-70 rpm to achieve 
agitation.121 For any selected apparatus a complementary analytical method is used to 
monitor the amount of drug released. The most common measurement methodology 
is UV-based, requiring minimal sample preparation.122 A drawback with single 
wavelength UV measurements is that it is difficult to gain information about the role 
of excipients such as the filler present within tablets. On top of that, there is the 
possibility of assay interface by excipients that adsorb in the same wavelength region 
or by undissolved excipients that could scatter light and skew the overall 
results.117,123,124 Such traditional dissolution testing are based exclusively on bulk 
solution concentration measurements as a function of time. Accumulation of solution 
concentration is needed. Thus, the lack of simultaneous real-time information about 
the solution concentration and the solid-state composition makes the detection of solid-
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state changes during dissolution difficult. This has motivated the developments of 
other approaches to improve the understanding of pharmaceutical tablets including UV 
imaging,125 FTIR spectroscopic imaging,126 Raman spectroscopy and NMR.123,127 
There is a desire for more sensitive and powerful methods to aid our understanding of 
drug behavior and/or drug formulations. Thus, the subsequent chapters of this thesis 
focus on the use of a range of scanning probe microscopy (SPM) techniques to probe 
dissolution and growth of pharmaceutical products.    
1.6. Scanning Probe Microscopies (SPMs)  
SPMs are a collective group of microscopes which branch from the scanning tunneling 
microscope (STM) that was first developed in 1981 by Gerd Binnig and Heinrich 
Rohrer.128 Its development earned them the Nobel Prize in physics in 1986. The most 
common factor in all SPMs is that they rely on a fine probe tip to sense and track a 
sample surface proving a very high-resolution image in three dimensions, potentially 
to the sub-nanometer range depending on the technique and the quality of the probe 
tip.  
1.6.1. Atomic Force Microscopy 
Of the SPMs, atomic force microscopy (AFM) is the most widely used in the field of 
drug delivery.129,130 The AFM was first introduced in 1986 by Binning and Rohrer as 
a new imaging methodology to obtain high resolution topographical images.131 It was 
created to circumvent the limitation of STM of which is the requirement of samples to 
be at least to some extent electrically conductive. Additionally, with AFM the ability 
to work under a range of environments is possible including in air and liquid over a 
range of temperatures.132-141 This in particular is beneficial for pharmaceutical studies, 
an example case will be studied in chapter 3.  
The fundamental understanding of the crystal morphology and surface chemistry of 
the crystal faces is crucial for the development of materials with specified chemical 
and physical characteristics. In view of that, Swift et al. used in situ AFM imaging to 
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study the dissolution of the (001) surface of cholesterol monohydrate single crystals in 
aqueous solutions.142 This has revealed different dissolution rates of the (001) and 
mechanisms that depend on the local surface topography. Additionally, Danesh et al. 
studied the dissolution of aspirin on the (001) and (100) faces.143 By monitoring step 
velocities, dissolution rates were obtained under acidic conditions.  
Tracking the early stages of crystallization is vital in understanding the overall 
mechanism and is strongly influenced by the crystallization conditions. Ward et al. 
carried out real time in situ AFM studies of the crystal growth of (melamine).(cyanuric 
acid) (M-CA) cocrystals in aqueous solution.144 The low solubility of such system is 
directly associated with its formation in the kidney causing renal failure in humans and 
animals. Crystal growth modes on specific crystal faces were revealed in addition to 
an important role for hydrophobic interactions between M–CA sheets in growth.144 
This can lead to the design of protocols for the prevention or treatment of renal disease 
caused by M–CA. Another example of the influence of growth conditions is the study 
of the crystallization mechanism of the pharmaceutical product Irbesartan, used to treat 
high blood pressure.145 Herein, the kinetic factors, such as temperature, 
supersaturation, and additives have shown to have an important role on the growth 
mechanism.  
In AFM, a sharp tip made of silicon or silicon nitride, which is typically between 1-20 
nm radium of curvature, is mounted on a 100-400 µm long flexible cantilever. The 
probe scans the surface in a raster motion (x and y-plane) and brought into and out of 
contact (z-plane) with the surface using a piezo-crystal. A laser beam is reflected from 
the back of the cantilever on to a segmented photodetector. There are different modes 
available for AFM imaging. The three principle modes will be considered here. Firstly, 
contact mode is when the tip is brought into and remains in contact with the surface at 
all times. It experiences a small force (of the order of nanoNewtons) as a result of 
interaction with the surface atoms. With contact force mode, a feedback loop is used 
to keep the deflection of the cantilever constant. As the cantilever is deflected, the z-
height is altered to allow a return to the original deflection, “set point”. Due to its ease 
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of use, contact mode is preferably used to image hard and flat surfaces.146 However, 
for softer surfaces, the development of so called tapping mode followed. Here, the tip 
is not always in contact with the surface, minimizing surface damage. The cantilever 
is chosen to oscillate at a value near its natural resonant vibration frequency (to be 
insensitive to vibrations and acoustic noise from surroundings). As the cantilever 
oscillates, the tip makes repulsive contact with the surface at the lowest point of the 
oscillation. Surface topography is obtained by a feedback mechanism which alters the 
z-height and keeps the oscillation amplitude constant. Thirdly, in non-contact imaging 
the tip is not in contact with the sample surface and is again oscillated in air but at 
smaller amplitude than in tapping mode. The interaction between the tip and surface 
are long range, van der Waals and electrostatic forces. This causes a detectable shift in 
frequency of the cantilever which is used in the feedback loop for the adjustment of z-
position, Figure 1.14 illustrates the basics of an AFM.  
Ultimately, AFM has been at the forefront of crystal studies but its relatively slow time 
resolution has limited this approach to systems with slow reaction kinetics, or has 
imposed careful selection of the solvent to further slowdown the kinetics. 
Nevertheless, AFM provided fundamental information about drug systems including, 
crystalline properties147-150, characterisation of pharmaceutical drugs151 and 
excipient152-154 and dissolution/growth139,155,156 kinetics of a range of systems.  
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Figure 1.14. (a) Schematic of the key features of an AFM, (b) different modes of AFM 
and (c) shows the force-distance curve. 
 
1.6.2. Scanning Electrochemical Microscopy 
Another powerful SPM technique for quantitative investigation of processes that occur 
at interfaces is the scanning electrochemical microscope (SECM) in which first studies 
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were performed in 1989 by Bard et al.,157 following earlier work from Engstrom in 
1986.158 SECM uses a UME tip to probe surface properties (such as topography and 
activity) by measuring the current caused from an electrochemical reaction occurring 
at the UME surface, as shown in Figure 1.15.159 In a typical SECM experiment, both 
the tip and sample substrate are immersed in an electrolyte solution containing 
electroactive species. If a potential is applied to the UME and scans laterally across 
the surface, changes in the current as a function of distance between the UME tip and 
substrate can be recorded constructing a topographical map of the surface. SECM is 
typically performed in a constant-height mode where the tip is scanned across the 
surface at a fixed height. Though, considering surface topographical changes and any 
sample tilt, scanning at constant height can lead to either, the tip losing the surface or 
tip crash during scan. SECM can alternatively be operated in constant-current mode 
where the tip tracks the surface maintaining a constant tip-substrate distance 
throughout the scan and recording the change in tip-substrate separation. Here, a 
feedback loop is used to adjust the tip position and provide a constant current. A 
drawback of this feedback mechanism is that it is affected by substrate activity and 
topography.159 Another mode of operation is the collective mode, which can either be: 
tip generation/substrate collection (TG/SC) or substrate generation/tip collection 
(SG/TC).159 In TG/SC, the UME is positioned near the surface and is held at a certain 
potential to detect electroactive species produced at the substrate. Conversely, in 
SG/TG, a potential is instead applied to the substrate, and current is measured at the 
UME. The use of collection mode SECM to study the dissolution of ionic crystals has 
been well implemented (vide infra).  
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Figure 1.15. Schematic of the principles of SECM showing hemispherical diffusion of 
the tip far away from the substrate surface, blocking of diffusion by insulating 
substrate and positive feedback at a conductive substrate. 
As highlighted above, with SECM, one can probe several properties of a chosen 
surface. One application is to probe concentration boundary layer of a crystal.160 The 
resulting flux from the crystal surface is transduced into a faradaic current collected at 
the UME. Ultimately, this may provide quantitative information about the rate and 
nature of the reaction. Using a UME as a working electrode has benefits: it provides 
high diffusion rates and small overall currents which allows studies under steady-state 
conditions.159 In addition, the achievement of small currents at the UME enables 
electrochemical measurements to be carried out in low conductance media such as 
organic solvents.161,162 The UME can also be used to induce and observe dissolution 
from a specific region of a crystal surface. This has been well-documented for the 
dissolution of ionic crystals.160,163-165 Having a saturated solution with respect to the 
solid crystal, by controlling the potential at the UME, the electrolysis of one or more 
types of the lattice ions in the solution can be initiated at a diffusion controlled rate. 
This results in the diffusion of dissolved ions from the crystal surface to be detected at 
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the UME producing a current flow. The magnitude of this observed current depends 
on the rate and mechanism of the dissolution reaction.  
 
1.6.3. Scanning Ion-conductance Microscopy 
The scanning ion-conductance microscope (SICM) was introduced by Hansma., 
around a similar time to SECM.166 Mainly used for topographical imaging. SICM uses 
a simple single barrel micro/nanopipette for probing an interface that is bathed in a 
conducting electrolyte solution. In a typical set-up, the pipette is filled with an 
electrolyte solution and a quasi-reference counter electrode (QRCE) is inserted and a 
second QRCE is placed in the bulk electrolyte solution. A voltage bias is then applied 
between the two QRCEs to initiate and drive ionic current through the end of the 
pipette, as shown in Figure 1.16.  
 
Figure 1.16. Schematic of SICM set-up. 
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The magnitude of the current that follows is determined by the resistance of the pipette 
and that of the electrolyte solution, when the tip probe is positioned far away from the 
substrate. Conventionally, as the tip moves towards the surface of interest, the ionic 
current decreases, most greatly seen when the probe-substrate distance is less than one 
tip diameter.167 This decrease in current response can be used as a sensor to track 
surface topography as the tip is moved across the substrate.  
SICM can be operated in different modes. In constant-distance mode, the position of 
the nanopipette is altered by a feedback loop mechanism in which piezo electric 
positioners maintain a constant current value that correspond to a constant probe-
substrate distance. It is typically scanned over the surface in a raster pattern. 
Alternatively, hopping mode can be implemented whereby, once the set point current 
value is achieved, as the tip approaches the surface (z-plane), the tip is retracted and 
moved across (x-y plane) to a new location before repeating the same approach. This 
scan hopping regime is particularly beneficial for probing samples with large height 
gradients that constant distance mode may not be able to track.167 The use of the ionic 
current as a means of feedback for topographical imaging is known as direct current 
(DC) feedback.  
Modulation techniques proved particularly powerful to avoid drift effects in DC 
current by the generation of an alternating current (AC) signal between the QRCEs. 
This is typically attained by oscillating the nanopipette normal to the surface at a set 
frequency (100 Hz-1000 Hz range) and a lock-in amplifier is then used to collect the 
ionic current at the same frequency, this is labelled as distance modulated (DM)-SICM. 
More recently, an alternative modulation technique known as bias modulation (BM)-
SICM has been developed by the Warwick group.168 Here, the AC signal is generated 
by modulating the bias between the QRCEs with a small amplitude. This approach has 
several advantages over DM-SICM, as, it allows the detection of surfaces when there 
is no net bias applied, overcoming concerns related to the use of strong bias for 
topographical mapping of cells due to intense electric field at the end of the tip.  
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SICM has developed over the years with these modulation techniques allowing more 
robust imaging capabilities. Major advances of SICM have led to its application in 
studying crystal dissolution in combination with other microscopy techniques for a 
complete reaction overview.169-171  Examples include crystal dissolution studies of the 
organic molecule Furosemide172 and kidney stones of L-cystine,136 in which BM-
SICM was used for tracking the changes in crystal height in aqueous media over time, 
subsequently, determining the dissolution rate of that face. Monitoring crystal height 
changes with BM-SICM minimizes the perturbations of the local ionic atmosphere. 
Additionally, it opens up the possibility of fast reaction mapping of surfaces.173  
 
1.6.4. Scanning Electrochemical Cell Microscopy  
There have been many developments in electrochemical SPMs to further their 
capabilities, particularly to create so called multi-microscopy techniques that can 
provide complementary parallel information about surfaces processes, such as (at 
least) activity and topography. The earliest simultaneous topographical and 
electrochemical measurement was achieved by a combined SECM-AFM approach.174-
176. Other combinatorial techniques include, SECM-SICM, SICM-AFM.169,171 The 
Warwick group has introduced SECCM.177,178 This latter technique is used for the 
studies in chapter 6. The probe used in SECCM is a theta pipette (double barrel) and 
simultaneous measurements of the topography and local functional properties of 
surfaces and interfaces are achieved. The basic idea is to place two QRCEs, often being 
silver chloride coated silver wires (Ag/AgCl), one in each barrel of the theta glass 
capillary and then to apply a potential bias between the two. Each barrel is filled with 
the electrolyte of interest. Figure 1.17 shows the basic setup. The potential difference 
drives the movement of ions between the two barrels, through the meniscus at the end 
of the pipette (direct current, DC). With the aid of a high resolution piezo-electric 
positioning system the electrochemical probe is positioned perpendicularly to the 
surface of interest. By the application of a small amplitude oscillation, typically a small 
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fraction of the pipette diameter, usually being 10 %,177 when the meniscus at the end 
of the pipette comes into contact with the surface an alternating current (AC) 
component of the conductance current develops.177-179 The AC amplitude is measured 
and used as a feedback parameter, ensuring constant contact between the 
electrochemical probe and the surface as well as maintaining a fixed sample-probe 
separation. AC and DC are simultaneously measured along with the electrode surface 
current and z-piezo position.177,179  
 
Figure 1.17. Schematic of SECCM setup. Theta pipette is used to create a tiny 
meniscus electrochemical cell on a substrate. The working electrode size is 
determined by the size of the pipette opening and meniscus wetting of the 
substrate. 
With a similar tip probe used in SECCM (i.e. dual barrel), the dissolution kinetics of 
the ionic crystal (NaCl) in aqueous solution has been previously reported.180 The 
solution in the pipette is undersaturated with respect to the crystal, and when the 
meniscus at the end of the pipette makes contact with a desired region of the crystal 
surface, dissolution and a change in the barrel conductance current is seen and 
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monitored with time. Its high solubility and relatively high dissolution fluxes, makes 
this system particularly challenging to study with techniques that require immersion 
of the crystal in a bulk solution such as in situ AFM. With SECCM, the crystal surface 
is only exposed to the solution where the meniscus makes contact allowing 
measurements to be made with submillisecond time resolution, allowing the possibly 
to study many systems of various solubility.    
 
1.7.  Nanopipettes 
Pipettes are proving increasingly powerful probes to investigate surface processes181-
185 not least because they can be prepared easily and rapidly from quartz or glass 
capillaries using a laser puller as illustrated in Figure 1.18 (a). Several types of 
nanopipette can be achieved depending on the initial capillary used that can result in a 
probe with a single, double or quad barrel as highlighted in Figure 1.18 (b).  And by 
adjusting the laser puller parameters a range of orifice sizes can be obtained.184,186 
Using nanopipettes allows the possibility of studying a wide range of processes at the 
early stages.183,187-189 This can provide unique and valuable information that can 
enhance the understanding of fundamental processes and help to elucidate complex 
reactions. Hence, chapters 4, 5 and 6 will show the use of such pipettes as an innovative 
approach to study the dissolution and growth of pharmaceutical drug products.   
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Figure 1.18. (a) Schematic mechanistic of the laser puller used to make the sharp 
nanopipette tips. (b) Illustration of the several types of nanopipettes that can be 
made with different capillaries. 
 
1.8. Resistive Pulse Detection  
Chapter 5 of this thesis will look at the use of nanopipettes as a reaction center to study 
crystallization of organic material at the nanoscale, though the use of Coulter counter 
principles. The Coulter counter, also known as a resistive-pulse counter, was first 
introduced in 1953 by Wallace Coulter for the analysis of micrometre-sized materials 
such as bacteria and cells.190 Traditionally, a Coulter counter consisted of two 
compartments that are separated by a small opening (20 µm-2 mm). Particles in the 
electrolytic solution are driven through the opening by the application of a potential 
bias or pressure gradient. An Ag/AgCl electrode is inserted into each compartment 
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(either side of the opening) to continuously record ionic current changes during particle 
translocation. As a particle translocates through the opening, a single resistive pulse 
signal is generated. Analysis of the obtained pulse signal (i.e. frequency, width and 
height) can provide information on size, quantity and surface charge properties of the 
translocating particle.191,192 Accordingly, solid-state and biological nanopores is a field 
that has advanced over recent years, with pore diameters ranging to a few 
nanometers.193-199  Likewise, by applying Coulter counter principles, nanopipettes can 
be used as resistive pulse sensors as illustrated in Figure 1.19.   
 
 
Figure 1.19. Schematic showing how nanopipettes can act as resistive pulse sensors. 
When a particle moves towards the pore the system feels an increase in resistance 
resulting in a drop in current as the particle translocates the pore. 
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Nanopipettes have previously been demonstrated to be powerful tools for driving the 
crystallization of inorganic crystals through driving the constituent ions together at the 
nanopipette orifice through the application of a bias.183,200,201 In addition, Perry et al 
reported crystallization and dissolution in real time of CaCO3 in aqueous solution with 
the use of nanopipettes. By controlling the bias between a quasi-reference counter 
electrode in the nanopipette and one in the bulk solution the ability to mix or de-mix 
two different solutions by ion migration can be initiated which drive either growth or 
dissolution.202  
 
1.9. Research Aims 
The fundamental aims of this research are to extend the understanding of dissolution 
and growth processes of APIs with low aqueous solubility, with innovative approaches 
that use high resolution SPM techniques. Further, it is shown in the final results chapter 
that some of the techniques developed are applicable to other areas, as exemplified by 
studies of an electrode material. 
Chapter 3 presents first results in this thesis. It centres on the study of the class II API 
bicalutamide as its low solubility/dissolution rate is a key factor limiting oral 
bioavailability and clinical applications. The aim here is to understand the fundamental 
factors which influence crystal dissolution, which could assist in enhancement of drug 
development and formulation. Thus, this chapter focuses on surface-selective studies 
under well-defined mass transport conditions. The dissolution kinetics of individual 
bicalutamide form-I microcrystals in aqueous solution by in situ AFM and finite 
element method (FEM) modelling is investigated. In addition, the importance of 
evolving high index crystal faces on the overall dissolution rates is explored. The final 
goal is to obtain a detailed quantitative and comprehensive view of the dissolution 
kinetics as well as concentration distributions of individual crystal faces.   
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Chapter 4 focuses on the understanding of the dissolution mechanism of ASDs in 
aqueous environments. The ASD of interest comprises felodipine drug in the water-
soluble polymer, copovidone. Dissolution performance of felodipine/copovidone ASD 
is highly dependent upon drug loading and so two very different drug loadings were 
investigated, 15% and 50%. The aim is to highlight the importance of drug loading on 
the dissolution of ASDs with a combination of electrochemical probing, in situ AFM 
and Raman analysis.  
Chapter 5 proposes a new method to study antisolvent crystallization at the nanoscale. 
As discussed above, crystallization in confined environments can have a significant 
impact on the properties of the emerging crystal structure. Herein, nanopipettes are 
used as a reaction center to study crystallization events of the API bicalutamide (class 
II) on the nanoscale with the aim of forming unusual polymorphs. This can be 
particularly exciting for pharmaceutical industries.  
SECCM is described in the introductory chapter. Chapter 6, provides an example of 
its application in studying the electro-oxidation of reduced nicotinamide adenine 
dinucleotide (NADH) on highly oriented pyrolytic graphite (HOPG) and 
polycrystalline boron-doped diamond (pBDD). Here, an overview of the technique 
will be illustrated as well its capability of elucidating such complex system.   
Chapter 7 finalises this thesis providing brief conclusions on the research and future 
perspectives.  
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Chapter 2  
Experimental 
_____________________________________ 
This Chapter provides a brief summary of the materials and chemicals used, 
experimental setup and instrumentation. More detailed additional information is 
provided in each chapter, specific to the work in that chapter. 
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2.1. Chemicals 
All chemicals were used as received and all solutions were prepared with high purity 
water (Purite, Select HP) with a resistivity of ca. 18.2 MΩ cm at 25°C. Chemicals were 
weighed using a four decimal place analytical balance (Sartorius A2008).Table 2.1 
lists all the chemicals used in this thesis. 
Table 2.1. List of chemicals used in this thesis. 
 
 
 
 
 
 
 
 
 
 
 
 
  
Chemicals Commercial source 
Potassium chloride (> 99.99%) Sigma- Aldrich 
Sodium chloride (> 99.99%) Sigma- Aldrich 
Phosphate buffer solution pH 7 Sigma- Aldrich 
β-Nicotinamide adenine dinucleotide, 
reduced disodium salt hydrate (≥ 97%) 
Sigma- Aldrich 
Felodipine amorphous solid dispersion AstraZeneca 
Ethanol (≥ 99.5%) Sigma-Aldrich 
Bicalutamide AstraZeneca 
Tetrabutylammonium chloride (≥ 
97.0%) 
Sigma- Aldrich 
Dimethyl sulfoxide (≥ 99.5%) Fisher 
Silver loaded epoxy adhesive RS components 
Alumina slurry (0.005 micron 
suspension) 
Buehler 
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2.2. Carbon Electrodes  
2.2.1. Highly Oriented Pyrolytic Graphite (HOPG) 
Highly oriented pyrolytic graphite (HOPG), consists of stacked graphene layers of 
well-defined structures (basal plane and step edges), as shown in Figure 2.1.  
 
Figure 2.1. Structural illustration of HOPG. 
The step edge density depends on sample preparation and treatment. Commercially 
available HOPG samples vary in step edge density and are graded according to their 
x-ray diffraction properties. In chapter 6, two different grades of commercially 
available HOPG were used: ZYB (NT-MDT) and SPI-3 (SPI supplies). A third HOPG 
sample was used which is not graded referred to AM. This originated from Arthur 
Moore and was kindly provided by Prof. R. L. McCreery (University of Alberta, 
Canada).  
The HOPG samples were cleaved using Scotch tape to achieve a freshly clean surface 
by peeling back the top layers. The direction of cleaving was maintained the same to 
avoid distortion of the surface. To establish an electrical connection, the HOPG sample 
was mounted and adhered onto a gold sputtered silicon wafer using silver paint (RS 
Components). Then an external electrical contact was made by connecting a 
conductive wire to the wafer by the use of adhesive Glue (RS Components) and silver 
paint. 
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2.2.2. Polycrystalline Boron-Doped Diamond (pBDD) 
Element six Ltd provided the pBDD samples used in chapter 6, were prepared using a 
commercial microwave plasma chemical vapor deposition process.1 Before they could 
be used as electrodes, a few preparation steps were followed. Firstly, to establish an 
electrical contact the diamond samples were back sputtered with a ~20 nm layer of Ti 
followed by a ~400 nm layer of Au using an Edwards E306 sputter/evaporator.  The 
samples were then left to anneal at 500 °C for 4 hours, during which titanium carbide 
is formed, critical for obtaining an ohmic contact. Next, the insulation of the pBDD 
samples was followed by sealing the diamond sample in glass capillaries (o.d. 2 mm, 
i.d. 1.16 mm, Harvard Apparatus Ltd, Kent, UK), using a heated filament capillary 
puller under vacuum. The pBDD sample was then pushed down to the sealed tip, 
holding a flat orientation allowing the exposure of the Ti/Au contact. Electrical contact 
was made to the BDD/Au surface using silver epoxy and connected to a conductive 
wire acting as an external electrical contact. The entire inner area of the capillary was 
filled with epoxy. Finally, the pBDD surface was exposed by polishing away the glass. 
This was done using grit paper disk grade and alumina (0.05 µm) paste (Buehler, 
Düsseldorf, Germany). Figure 2.2 shows a schematic diagram of a pBDD 1 mm 
diameter disk macro-electrode. 
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Figure 2.2. (a) Schematic diagram of the in-house fabricated pBDD electrode. (b) An 
optical microscope image of pBDD electrode face with a diameter of 1 mm. 
 
2.3. Macroscale Electrochemistry  
For the macroscopic voltammograms carried out on HOPG in chapter 6, all samples 
were mounted on gold coated (100 nm) silicon wafers by using Acheson Electrodag 
(Agar Scientific, 1415M). An electrical contact was made between the HOPG and 
silicon wafer by attaching a metal wire to the gold surface. A 3 mm in diameter Teflon 
cell was used to give a well-defined working area. Using piezon grease carefully 
applied to the cylinder end in a small amount, the cell was placed on the surface of the 
HOPG and filled with the solution of interest, as shown in Figure 2.3. 
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Figure 2.3. Schematic of the Teflon cell used to hold solution on HOPG with a defined 
contact area. 
2.4. Quad-Probe Fabrication  
The carbon based quad probes used in chapter 4 were fabricated from quartz 
quadruple-barrelled capillaries (MBT-015-062- 4Q, Friedrich and Dimmock, Inc.).2 
As discussed in the introduction, the capillaries were pulled to sharp point pipettes 
using a laser puller (p-2000, Sutter Instruments). In order to form a double barrel 
carbon probe for localized chemical detection and distance feedback control the 
following procedure was undertaken:  
Two of the barrels were internally coated with carbon by making sure the remaining 
two barrels were closed using Blu-Tack (Bostik, UK). Carbon was deposited inside 
the sharp end of the pipette by the pyrolytic decomposition of butane under argon 
atmosphere using a gas blow torch (RS Components), as demonstrated in Figure 2.4. 
After carbon deposition, electrical contact was made by inserting a platinum wire 
through the top end of the pipette barrel to contact the carbon layer. The other two 
barrels were left unmodified, filled with electrolyte and were used for distance 
control.3-5 
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Figure 2.4. Schematic of the carbon deposition process for the fabrication of a quad-
probe. Butane is passed through the pulled pipet barrels and pyrolyzed using a hand 
held butane torch under an argon atmosphere. 
2.5. Preparation of Bicalutamide Microcrystals 
For the investigation of the aqueous dissolution kinetics of bicalutamide (BIC) 
represented in chapter 3, optically clear crystals were used, grown following the 
solvent-antisolvent crystallization method.6 In the typical experiment, 10 mM BIC 
solution was made using a mixture of ethanol and dimethyl sulfoxide, DMSO in 5:1 
ratio. BIC is fairly soluble in ethanol (7 mg/ml at 25 °C) and highly soluble in DMSO 
(86 mg/ml at 25 °C). This organic solution containing BIC was labelled as the 
“solvent” and the aqueous solution as the “antisolvent”.  200 µl of BIC was added to 
400 µl H2O and the growth of crystals was initiated on the plastic surface of a petri 
dish under closed environment. After leaving it stationary in the fluid mixture for 15 
min, the surface was rinsed with water and dried using nitrogen. This method produced 
crystals with a largest dimension of 10-40 µm, holding a coffin like morphology as 
shown in Figure 2.5. Prior to any crystal analysis, the crystals were carefully inspected 
optically for cracks and rinsed with ultra-pure water then dried with nitrogen gas. 
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Figure 2.5. Optical images of BIC crystals  
2.6. Peak Force Tapping Atomic Force Microscopy  
AFM images recorded in chapter 3 were carried out using a BioScope CatalystTM 
BioAFM in ScanAsyst mode.7 ScanAsyst uses Peak Force Tapping (PFT) mechanism, 
which works similarly to the standard tapping mode, except that it operates in a non-
resonant mode. This provides low tapping frequency range that is well below the 
cantilever resonance thus, decoupling cantilever response from resonance dynamics. 
This oscillating system allows direct force control of damaging lateral forces, which is 
very useful for the topographical imaging of soft samples.  
In PFT, the tip is oscillated in the z-position with small amplitude of 100−300 nm 
(depending on the environment and surface characteristics) and at a specific frequency 
of 0.25-2.0 kHz.7, 8 The z-position is modulated with a sinusoidal wave rather than a 
triangular one used in conventional force-distance curves resulting in very fast force–
distance curves for each image pixel. The maximum probe–sample interaction force 
(peak force) of each curve is used to control vertical forces. Illustrated in Figure 2.6 
(i), as the tip approaches the sample surface (A), it experiences attractive forces (long-
range van der Waals) and moves towards the surface (represented by the negative 
force). As the attractive forces become greater than the cantilever stiffness, the tip gets 
pulled and comes into contact with the surface (B). The force between the tip and 
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surface increases until the Z position of the modulation reaches its lowest peak point. 
This is where the maximum force between the tip and the sample occurs (C) and is 
maintained constant by a system feedback mechanism. Then as the tip withdraws from 
the surface, the force decreases until it reaches a minimum point (D). Once, the tip is 
completely off the surface, it only experiences long range forces. When the tip-sample 
separation is maximum, the force if very small or zero (E).      
 
Figure 2.6. (i) Plot of fore and z position as a function of time. (ii) Force versus Z 
positon, typical force curve performed at every pixel position on the sample surface. 
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Chapter 3  
Dissolution of Bicalutamide Single Crystals in 
Aqueous Solution: Significance of Evolving 
Topography in Accelerating Face-Specific 
Kinetics 
_____________________________________ 
The dissolution kinetics of individual microscale bicalutamide (BIC) form-I crystals 
are tracked over time using in situ atomic force microscopy (AFM), with the evolution 
of crystal morphology used to obtain quantitative data on dissolution kinetics via finite 
element method (FEM) modeling of the dissolution reaction-diffusion problem. 
Dissolution is found to involve pit formation, and roughening on all dissolving 
surfaces of the BIC crystal and this has a strong influence on the overall dissolution 
process and kinetics. While all of the exposed faces (100), {051} and {1¯02} show 
dissolution kinetics that are largely surface-kinetic controlled, each face has an 
intrinsic dissolution characteristic that depends on the degree of hydrogen bonding 
with aqueous solution, with hydrogen bonding promoting faster dissolution. 
Moreover, as dissolution proceeds with pitting and roughening, the rate accelerates 
considerably, so that there is an increasing diffusion contribution. Such insight is 
important in understanding the oral administration of poorly soluble active 
pharmaceutical ingredients (APIs) in crystal form. Evidently, surface roughening and 
defects greatly enhance dissolution kinetics, but the evolving crystal topography 
during dissolution leads to complex time-dependent kinetics that are important for 
modeling and understanding API release rates. This work is published in Crystal 
Growth & Design. 
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3.1. Introduction 
Many active pharmaceutical ingredients (APIs) are administered as solid oral 
formulations,1 and the resulting in vivo bioavailability is governed by properties such 
as solubility, permeability, and formulation components, as well as physiological 
variables. As formulations often include APIs in microcrystalline format, strong 
dependency of API bioavailability on the dissolution rates of the API crystals has been 
recognized2-4 and, consequently, dissolution measurements are a key procedure in drug 
testing and quality control of pharmaceutical products.5,6 Interestingly, there is an 
increasing trend towards the use of poorly water soluble compounds as candidates for 
the development of new drugs,7 and a comprehensive understanding of the dissolution 
process of these crystalline APIs is thus of fundamental importance.  
The dissolution of a crystal is a complex physicochemical process driven by local 
undersaturation at the crystal/solution interface, and consisting of a series of 
elementary steps involving various surface reactions and mass transport.8 The slowest 
step(s) governs the overall rate and at the simplest level dissolution kinetics can be 
classified as either surface-controlled (surface processes limit the rate), mass transport-
controlled (surface processes are faster compared to diffusion of API molecules from 
the crystal to bulk solution) or under a mixed regime system, where surface processes 
and mass transport contributions to the kinetics are comparable. The dissolution 
process is further complicated when the nature of a molecular crystal surface is 
considered in more detail. The different arrangement of molecules at different exposed 
crystal faces and the surface microstructure of those faces (steps, terraces and kinks) 
make crystal surfaces energetically heterogeneous.9,10 The dissolution rate will depend 
on the energetics associated with each type of site on each surface,11-14 and their 
contributions and interactions greatly complicate the understanding of the dissolution 
processes (kinetics and mechanism).13,15 Experimental studies need to provide an 
holistic view16 of the impact of surface morphology, surface reactivity, driving force 
and mass transport on dissolution kinetics.   
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Traditional dissolution testing methodologies for APIs are based solely on measuring 
bulk solution concentration of a dissolving suspension of a particulates as a function 
of time.17,18 These approaches give average dissolution rates of a population of crystals 
but do not provide any information about the contribution of the individual crystal 
faces or the micromorphology changes during the dissolution process.19-21 
Furthermore, difficulties in the quantification of mass transport in such systems 
impedes the elucidation of the driving force for dissolution (undersaturation at the 
crystal/solution interface). 
The use of scanning probe microscopy methods such as atomic force microscopy 
(AFM),8,22-24 or scanning ion conductance microscopy (SICM),25 among others,26,27,28 
has provided detailed kinetic and structural information of dissolution processes. The 
study of microcrystals by these techniques is particularly advantageous, as this 
configuration offers high diffusional mass transport rates between the crystal and bulk 
solution and the possibility of mapping the behavior of entire crystals and the different 
faces exposed.25 Furthermore, this approach allows the ready combination of 
experimental data with numerical simulations of mass transport and surface kinetics, 
making it possible to determine concentration gradients and interfacial concentrations, 
so as to quantify the dissolution kinetic regime.  
The microcrystal approach is adopted herein, using a combination of in situ AFM 
imaging data and finite element method (FEM) simulations, to probe face-specific 
dissolution of bicalutamide (BIC) (Scheme 3.1) crystals as a function of time. BIC is 
the API in AstraZeneca’s product CASODEX®29 and belongs to class II of the 
biopharmaceutics classification system (BCS) (low solubility and high permeability). 
It is used to prevent the growth of prostate cancer by blocking the action of androgens 
on cancer cells.29-31 The low solubility/dissolution rate of BIC is a major limiting factor 
for its bioavailability and clinical applications. Accordingly, an in-depth understanding 
of the microscopic dissolution process in aqueous solution at the single crystal level is 
expected to be important in leading to new formulation strategies that would enhance 
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its bioavailability. The approach outlined herein could be generally powerful for 
revealing the dissolution kinetics of class II API crystals. 
  
 
Scheme 3.1. Molecular structure of bicalutamide 
 
3.2. Experimental Section 
3.2.1. Solutions and Sample Preparation 
All chemicals were used as received. Aqueous solutions were prepared using high 
purity water (Purite, Select HP) with a resistivity of 18.2 MΩ cm at 25 °C. BIC was 
supplied by AstraZeneca. BIC crystals were grown by mixing 200 µL of a 10 mM 
solution of BIC dissolved in a mixture of ethanol (≥ 99.5%) and dimethyl sulfoxide (≥ 
99.9 %) in 5:1 v/v ratio (solvent) with 400 µL of water (antisolvent) in a plastic petri 
dish (Willco Well) to create a supersaturated solution. The solution was allowed to 
stand under a closed environment for 15 min. The supernatant was then removed to 
reveal plate-like crystals, with the largest dimension in the range 10-60 µm, attached 
to the petri dish base. The crystals were then rinsed briefly with ultra-pure water and 
dried using nitrogen (BOC).  
3.2.2. X-ray Characterization 
Single crystal X-ray analysis was used to determine the unit cell of the grown crystals. 
A large crystal (100 µm in length, grown for 1 hour) was mounted on a Mitegen loop 
Chapter 3 
 
67 
 
with silicone oil and placed on an Oxford Diffraction Xcalibur Gemini diffractometer 
fitted with a Ruby CCD area detector. The crystal was kept at 293(2) K during data 
collection. Using Olex2,32 the structure was solved with the ShelXS-201333 structure 
solution program using Direct Methods and refined with the ShelXL34 refinement 
package using least squares minimization. The face indexing was performed using 
CrysAlis PRO (Agilent Technologies UK Ltd.). Powder X-ray diffraction analysis was 
executed at room temperature using Panalytical X’Pert Pro MPD with hybrid 
monochromator to give pure CuK1 radiation (1.541 Å). The bottom of the petri dish 
containing the crystals was cut and placed on the sample holder. A Pixcel detector was 
used in scanning mode over the range 5° < 2θ < 30°, stepping 0.02° over a period of 
45 min.   
3.2.3. In Situ Atomic Force Microscopy 
Dissolution investigations were performed in 2 mL of unstirred pure water (sink 
conditions) directly in the petri dish containing the crystals, as grown, using a Bioscope 
Catalyst microscope with a Nanoscope V controller (Veeco). AFM images of selected 
diffusionally isolated crystals ( 35 µm in length; separated from neighboring crystals 
by >20 times this distance) were acquired in ScanAsyst mode using silicon-tips on a 
silicon nitride lever with a spring constant of 0.35 Nm-1 according to manufacturer 
(SNL-10, Bruker) The images were obtained at a scan rate of 0.45 Hz and the 
temperature was ca. 20 °C. Dissolution rates were measured from consecutive frames 
acquired at 10 min per frame with a resolution of 256 lines and 512 samples per line. 
Images acquired were analyzed using SPIP 6.0.14 software, where a first order plane 
correction was applied making sure the crystal was masked out to correct any 
background tilt. ISO 11562 Gaussian profile filter was implemented to separate the 
long and short wave content of a surface profile (roughness and waviness). 
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3.2.4. Finite Element Method Simulations 
Numerical simulations were performed on a Dell Intel core 7i Quad 2.93 GHz 
computer, equipped with 16 GB of RAM running Windows 7 Professional x64 bit 
edition using the commercial FEM modelling package Comsol Multiphysics 4.2a 
(COMSOL AB, Sweden). The “mass transport of diluted species” module was used in 
the 3D domain illustrated in Figure 3.1 to simulate the mass transport of BIC 
dissolution during the in situ AFM experiments. The models were defined using 
experimental data that included changes in both the crystal size and morphology and 
dissolution rates at specific dissolution times. Calculations employed >12000 
tetrahedral mesh elements and resolution was defined to be finest near the surface of 
the crystal. Solution of the partial differential equations for each model was achieved 
using the direct solver MUMPS in the COMSOL environment with a relative error 
tolerance of 10–6. 
 
 
Figure 3.1. Three-dimensional domain (not to scale) used for FEM 
simulations of BIC dissolution. The numbers correspond to the boundaries 
described in Table 3.1. 
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For the experimental length scale, mass transport is predominantly by diffusion. The 
diffusion time can be estimated using a semi-infinite diffusion model according to 
equation 1, where tdiff is the steady-state diffusion time, d is crystal largest dimension 
length and D denotes diffusion coefficient.  
                                    (1) 
The diffusion coefficient of BIC molecules in aqueous solution (D = 4.5 × 10-6 cm2 s-
1) was calculated using the Wilke-Chang equation (equation 2), where where D is the 
diffusion coefficient, ∅ is the association parameter for the solvent, 𝑀𝐵 is the molecular 
weight of the solvent, μ is the viscosity of the solvent, 𝑉𝐴 is the molecular volume of 
the molecule and T is temperature. It provides diffusivities with an absolute error no 
bigger than 11%,34 a level that did not have a major impact on our final results. 
𝐷 =  
7.4×10−8 × (∅ ×𝑀𝐵)
0.5× 𝑇
𝜇 × 𝑉𝐴
0.6              (2) 
FEM simulations taking into account the upper and lower limit of the diffusion 
coefficient calculated from the Wilke-Chang correlation showed that the absolute error 
in the calculation of the solute concentration near the crystal/solution interface and the 
flux of solute from each individual crystal face was < 11 %, a precision that was 
sufficient not to affect our conclusions about the kinetic regime. For the dilute 
solutions during dissolution, D was assumed constant over the entire domain. The 
characteristic diffusion time for a dissolving crystal (35 m in length) is about 3 s, 
which is about 4 orders of magnitude faster than the duration of a typical dissolution 
experiment (6 h). Mass transport by diffusion was therefore assumed to be at a steady-
state, for particular AFM snapshots, and the flux conservation equation (equation 3) 
was solved, where J is the flux and c is the concentration of the BIC solute. 
∇𝐽 = −𝐷∇2𝑐 = 0                                     (3) 
Four different geometric models were developed that mimicked the main crystal 
morphologies found during dissolution. For each model, the experimental data of face 
Ddtdiff /
2
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displacement velocity allowed the flux (per unit area) for each crystal face, J{hkl},
13
 to 
be defined. These form the boundary conditions on the crystal surface which, together 
with the remaining boundary conditions (Table 3.1), allowed equation (3) to be solved 
to obtain the concentration of BIC in the solution around the dissolving crystal. These 
simulation data allowed evaluation of the dissolution regime, i.e., mass transport vs. 
kinetic control, as a function of time. In order to deduce the relative importance of 
mass transport and surface kinetics, two additional sets of models with the same 
geometry but different boundary conditions were employed (Table 3.1), such that 
dissolution of all the crystal faces was controlled by diffusion (crystal/solution 
interface saturated with soluble BIC), denoted MT1 models, or where only the small 
and fast dissolving crystal faces {051} and {1¯02} were controlled by diffusion, 
denoted MT2 models.  
Table 3.1. Boundary conditions applied to the numerical models as defined in Figure 
3.1, where n denotes the outward vector normal to the boundary, cbulk is the bulk 
concentration (0 µM) and csat is the saturation solubility of 11.6 µM. 
Boundary Experimental conditions 
Mass transport control 
conditions 
1-5   
6   
7, 8, 10, 11   
9, 12   
13   
c = cbulk c = cbulk
0)(  cDn 0)(  cDn
tJcD },051{)( n c = csat
t
JcD
},021{
)( n c = csat
tJcD },100{)( n c = csat
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3.3. Results and Discussion  
3.3.1. Bicalutamide Crystals 
The solid form of BIC presents polymorphism, which has been thoroughly 
characterized by Vega et al.29 Two crystalline forms (I and II) and an amorphous phase 
of solid BIC have been reported. Single crystal CCD X-ray diffraction determined that 
the crystallization method described herein produced polymorph I, which is the most 
stable form, characterized by the monoclinic P21/c space group as shown in table 3.2. 
Optical microscopy revealed the crystals had a plate-like crystal habit, as shown in 
Figure 3.2 (a). The orientation of the crystals grown in the plastic petri dish was 
determined by powder X-ray diffraction. Only peaks corresponding to the (h00) 
reflections (h=1-4) were observed, indicating that the crystals were oriented with the 
(100) faces parallel to the surface, as shown in Figure 3.3. The remaining faces were 
determined by single crystal X-ray diffraction taking into account the specific angles 
of the crystal faces. The (hkl) indexes assigned to each crystal face are presented in 
Figure 3.2 (b). 
 
Figure 3.2. Crystal morphology of BIC (Form I). (a) Bright field microscopy image of a 
typical grown crystal acquired normal to the (100) face. (b) Representation of the 
single crystal X-ray diffraction of BIC with crystal faces assigned. Red line represents 
the 2D crystal outline. 
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Figure 3.3. Comparison of calculated and experimental PXRD patterns of BIC 
polymorph I 
 
Table 3.2. Crystal data and structure refinement for BIC 
Identification code BIC 
Empirical formula C18H14F4N2O4S 
Formula weight 430.37 
Temperature/K 296(2) 
Crystal system Monoclinic  
Space group P21/c 
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a/Å 14.9237(5) 
b/Å 12.2149(3) 
c/Å 10.4612(3) 
α/° 90 
β/° 104.668(3) 
γ/° 90 
Volume/Å3 1844.84(10) 
Z 4 
ρcalcmg/mm3 1.550 
m/mm‑1 2.201 
F(000) 880.0 
Crystal size/mm3 0.4 × 0.18 × 0.05 
Radiation CuKα (λ = 1.54184) 
2Θ range for data collection 6.122 to 155.976° 
Index ranges -18 ≤ h ≤ 15, -7 ≤ k ≤ 15, -11 ≤ l ≤ 12 
Reflections collected 7177 
Independent reflections 3820 [Rint = 0.0233, Rsigma = 0.0310] 
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Data/restraints/parameters 3820/11/282 
Goodness-of-fit on F2 1.038 
Final R indexes [I>=2σ (I)] R1 = 0.0478, wR2 = 0.1344 
Final R indexes [all data] R1 = 0.0547, wR2 = 0.1418 
Largest diff. peak/hole / e Å-3 0.52/-0.33 
 
3.3.2. Dissolution Rates and Surface Dynamics 
Herein, the aqueous dissolution kinetics of microscopic BIC single crystals has been 
studied by AFM imaging in quiescent conditions. As discussed in the introduction, 
visualization of the morphology changes of an entire single crystal during dissolution 
allows the assessment of the dissolution rates of individual crystal faces, providing 
information on the evolution of surface structure and dissolution activity.35 
Additionally, the use of microcrystals generates fast and well-defined mass transport 
that can be modeled, enabling the quantification of the relative contributions of mass 
transport and surface kinetics to observed dissolution rates. ScanAsyst mode36 was 
chosen to operate at very low forces, which minimized tip/sample interactions while 
enabling high resolution images to be obtained. Additionally, in order to determine if 
the AFM probe had an effect on dissolution kinetics, dissolution studies of 
diffusionally isolated BIC single crystals of similar size were performed by optical 
microscopy. The total dissolution time measured by optical microscopy was broadly 
comparable to that determined by AFM such that it was possible to discard AFM tip 
effects promoting the dissolution of the crystals. Other possible effects of the AFM 
probe on the mass transport of species diffusing from the crystal surface to bulk 
solution were also considered. As shown in previous work,37-39 the AFM tip can block 
the diffusion of solute and affect the elucidation of the kinetic regime, especially when 
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the crystal dissolves under a mixed kinetic regime and a very small area of the crystal 
surface is imaged. However, in the case reported in this work, FEM results show that 
the dissolution of BIC crystals, in particular the (100) face, is strongly controlled by 
surface kinetics and small changes in the mass transport of BIC due to the AFM probe 
can be neglected. Moreover, the whole crystal is imaged by the AFM probe, allowing 
the natural mass transport behavior of the system to be quickly recovered when the tip 
moves laterally a few microns, as shown in other works that studied the influence of 
AFM probe position and geometry on diffusion to ultramicroelectrodes in an in situ 
AFM environment.40  
Measurements were made on different crystals, and although there were some 
differences between them, the phenomena observed and the time course of dissolution 
was broadly similar. The data in detail for one crystal are provided below and further 
examples will be provided later on in this chapter. Figure 3.4 (a) presents time-
dependent 3D AFM images of a dissolving BIC microcrystal in aqueous solution. In 
the early stages, AFM measurements show the formation of pits on the top surfaces, 
as well as roughening of the side faces. The dissolution velocity of the (100) faces was 
followed by tracking the changes in the average crystal height over the entire crystal 
area as a function of time, whereas the dissolution velocities of the {051} and {1¯02} 
faces were determined from the perpendicular retreat of the faces as referenced in 
Figure 3.4 (b). The mean of the 2 cross-sectional lines, forming right angles between 
parallel {051} faces, as shown in Figure 3.4 (b), was used as the average width. The 
mean of 9 cross-sectional lines along the direction labeled as length in Figure 3.4 (b) 
was used to extract the average length of the crystal at each frame. Measurements were 
extracted for all dimensions until the dissolution time reached 240 mins. Within this 
time range, measurements could be made with good certainty, since the crystal showed 
a well-defined morphology. Figure 3.4 (c) plots the displacement behavior in the 
length and width dimensions. The displacement slope of the {1¯02} faces (length) is 
steeper than the {051} faces (width), indicating faster dissolution rate. The increase in 
rate with time can be understood from visual analysis of the AFM images, showing 
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that the initiation and propagation of pits, and face roughening, over time have a great 
impact on the rate at which the BIC crystal faces dissolve.  
 
Figure 3.4. (a) AFM images of a single BIC microcrystal (initially 36 µm in length and 
10.5 µm in width) during dissolution in aqueous solution. (b) 2D BIC crystal 
morphology indicating how displacement data were extracted. (c) Plot showing the 
changes in width and length over time of the dissolving BIC crystal shown in (a). 
The overall displacement of the (100), {051} and {1¯02} faces with time fit well to an 
exponential function (Figure 3.4 (a)). Data were fitted empirically to such a function 
(equation 4) to yield the best R2 value included in the software OriginPro 9.1.0. 
𝑦 = 𝐴(1 − 𝑒𝑥𝑝−𝐵𝑥)                       (4) 
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The best linear fits in the early and late time period are shown by the blue dotted lines. 
Molar dissolution rates of the individual crystal faces were determined directly from 
the data in Figure 3.4 (a) using equation 5, where v(hkl) is the dissolution velocity of the 
{hkl} face (gradient / 2 of the plots in Figure 3.5 (a) (only for the width and length)) 
and Vm(BIC) is the molar volume of BIC calculated from the density of the BIC 
polymorph (1.55 g cm-3). 
𝑚𝑜𝑙𝑎𝑟 𝑓𝑙𝑢𝑥 =  𝑣(ℎ𝑘𝑙) × 𝑉𝑚(𝐵𝐼𝐶)            (5) 
The slowest dissolution rate was found to be for the (100) face. The dissolution rates 
of the {051} and {1¯02} faces were faster, but both increased markedly with time 
(Figure 3.5 (b) (ii-iii)). As alluded to above, these changes are mainly associated with 
changes of the crystal surface energy, due to the evolving face topography. 
Further insight into the dissolution process was obtained by conducting an analysis of 
the relationship between dissolution rate and surface roughness, as determined by 
AFM, normalized by the changes in geometric surface area as a function of time 
(Figure 3.5 (c)). This procedure is most accurate for the top (100) face because full 
images of the surface are obtained in detail. It can be seen that surface area-normalized 
roughness increases by less than a factor of two, yet the rate of reaction over this time 
period increases by a factor of six. Although AFM may not provide a view of atomic-
scale defects, it appears that the rate is not simply proportional to surface roughness. 
Rather as dissolution proceeds, sites of higher reactivity, including high-index 
nanofacets, are produced which accelerate the reaction.    
The roughness of the {051} and {1¯02} faces is more difficult to quantify, but it can be 
seen from Figure 3.5 (a) (ii) and (iii) and (b) (ii) and (iii) that the dramatic increase in 
rate is far more extensive than could be explained from the roughening of the crystal 
side faces (Figure 3.4 (a)). Indeed, these images highlight the formation of high index 
faces (manifested as indents) around the crystal perimeter.  
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Figure 3.5. (a) Plots showing changes in crystal dimensions over time: (i) Height 
(100), (ii) Width {051} and (iii) Length {1¯02}. (b) Corresponding dissolution rates (flux) 
over time: (i) Height (100), (ii) Width {051} and (iii) Length {1¯02}. Data are fitted to an 
exponential function (solid red curves) and the blue linear portions highlight the 
change in the rate for the basal surface and roughened surfaces at early and 
advanced dissolution times. (c) Plot showing the change in surface roughness of 
(100) face normalized by the geometric surface area as a function of time. 
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Initially, the crystal faces are relatively flat (low step edge and kink density), so the 
overall activation energy for dissolution tends to be larger.41 The data presented 
indicate that as dissolution proceeds, the crystal surface roughens, the edges become 
rounded and new crystal faces of higher crystallographic indexes are exposed to the 
solvent as shown in Figure 3.6.  
Etch-pits produced on the (100) face, imaged directly by AFM (Figure 3.4 (a)), show 
that the distribution is non-uniform and etch-pits do not present a particular 
crystallographic orientation. All the crystal faces present high-degree of surface etch-
pitting at long dissolution times, which explains the slope difference in the two linear 
regions of all plotted dissolution rates versus time, in Figure 3.5 (b), and the newly 
exposed reactive sites cause the increase in the dissolution rate.42, 43 The dissolution of 
additional crystals were analyzed to confirm this observations, as shown below in 
Figures 3.7-9). 
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Figure 3.6. Graphs showing cross-sections of dissolved BIC crystals at various time 
points. 
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Figure 3.7. AFM topography images of aqueous dissolution sequence of 3 different 
single BIC crystals. 
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Figure 3.8. Plots showing changes in crystal dimensions over time of the 
crystals shown in Figure 3.7. 
 
Figure 3.9.Corresponding dissolution rates (flux per unit area) over time of the 
crystals shown in Figure 3.7. 
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Plots in Figure 3.9 illustrate that as the crystal starts to roughen the dissolution rate 
increases significantly. The order of the measured dissolution rates for all three crystals 
was found to be: (100) < {051} < {1¯02}.  
Although all examined BIC crystals showed broadly similar behavior, they dissolved 
at different rates despite their similarity in size (∼50-60 µm in length). This is 
attributed to the different crystal surface characteristics, such as the number and type 
of defects in each crystal, which with time increasingly lead to the emergence of high 
index faces that impact on dissolution kinetics at longer times. The creation of reactive 
dissolution sites is considered to be an indicator of surface-controlled dissolution,9,10,13 
but to confirm the kinetic regime, the determination of the solute concentration near 
the crystal/solution interface and the quantification of the surface reactivity and 
diffusion contributions to the dissolution process is necessary (vide infra). These 
observations build on our recent dissolution kinetics measurements of salicylic acid in 
aqueous solution using hopping intermittent contact scanning electrochemical 
microscopy27 and the aqueous dissolution of the organic crystal, furosemide, using the 
combination of scanning ion conductance microscopy and optical microscopy.25 Both 
studies highlight the strong influence of evolving surface roughness on the overall 
dissolution kinetics time-course.   
The face-specific dissolution rates at the beginning of the dissolution process 
corresponds to the dissolution of the (100), {051} and {1¯02} faces presented in the 
initial crystal habit. As highlighted above, crystal surface energy has a huge impact on 
the overall dissolution rate, and this was examined, as shown in Figure 3.10 (generated 
using the unit cell parameters of the crystal structure JAYCES available in the CCDC29 
and using the commercial package Mercury 3.8, CCDC Cambridge44). Considering 
the (100) face presented in Figure 3.10 (a), the hydrogen bonding network is contained 
within the (100) plane with the exposure of fluorobenzene rings at the surface. This is 
the characteristic of a face with a low surface energy and slow growth.45 In contrast, 
the (1¯02) face structure (Figure 3.10, (b)), exposes a sulphonyl group at the surface 
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and results in a hydrogen bonding network perpendicular to the (1¯02) plane, making 
the (1¯02) face a high energy surface. This behavior is also seen in the (051) face, 
although to a smaller extent compared to the (1¯02) face, highlighted by the exposure 
of trifluoromethyl benzonitrile group at the surface and the zig zag arrangement of the 
hydrogen bonds along the structure shown in Figure 3.10 (c). The order of the 
measured dissolution rates (Figure 3.5 (b)) of the different faces: (100) < {051} < {1¯
02}, agrees with the hydrogen bonding model, i.e. the greater the degree of hydrogen 
bonding between the surfaces and adjacent solution, the faster the dissolution kinetics. 
It is reasonable to assume that the relative dissolution rates of the different faces for 
this period of time would mirror the order of the attachment energies of BIC molecules 
to the surface, as would occur during crystal growth, and as found in our previous work 
on furosemide.25  
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Figure 3.10. Stucture of BIC crystal faces: (a) (100), (b) (1¯02) and (c) (051). Black 
dotted lines highlight hydrogen bonds. Acquired using Mercury 3.8, CCDC Cambridge 
using the structure JAYCES. 
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3.3.3. Determination of Interfacial Concentrations and Kinetic Regime 
In the case of a mixed surface kinetic-diffusion regime, the concentration of solute 
molecules near the crystal surface has an intermediate value between close to bulk 
concentration (pure kinetic control) and equilibrium (saturated) value (diffusion 
control). The actual value depends on the relative contributions of mass transport and 
surface kinetics.39 To elucidate how the kinetic regime during the dissolution of BIC 
crystals evolves with time, the concentration of BIC solute near the crystal/solution 
interface during dissolution was calculated by FEM simulations formulated directly 
from AFM experimental data.  
Because the crystal size, morphology and dissolution rates of the individual crystal 
faces are time-dependent, four different steady-state FEM models at different 
dissolution times were formulated to evaluate the evolution of the kinetic regime with 
time. The computations used the experimental dissolution rates determined for each 
crystal face and the crystal size and morphology determined from AFM images at each 
dissolution time (20 min, 80 min, 170 min and 230 min). The crystal morphology was 
approximated to smooth surfaces, i.e. to the underlying basal surface, considering the 
difficulty of constructing and assigning overall dissolution rates to rough surfaces in 
the FEM modelling package. The results of the FEM calculations (Figure 3.11 (a)) 
revealed that csurf {1¯02} > csurf {051} > csurf (100) during the whole dissolution process, and 
that all the csurf {hkl} values increase with time consistent with the kinetic coefficient for 
dissolution increasing as dissolution proceeds. At the beginning, csurf {hkl} is very 
similar to the bulk concentration. This is consistent with a dissolution process 
controlled by surface kinetics in which the rate of the surface reaction is much slower 
than the rate of surface to bulk diffusion. As dissolution proceeds, AFM imaging 
indicates that more reactive sites are formed and surface dissolution kinetics increase, 
leading to higher csurf {hkl}. Consequently, concentration gradients from the crystal to 
bulk solution become steeper, indicating an increasing contribution from diffusion. 
However, surface kinetics still dominate, since csurf {hkl} is well below the equilibrium 
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concentration value (11.62 µM, at 20 C)46 during the entire dissolution process (see 
supporting information, section 3.5.1).  
To evaluate the relative contributions of mass transport and surface kinetics on 
dissolution, these results were compared to those obtained from FEM calculations 
parameterized for the same crystal size and geometry at each dissolution time, but 
where a pure diffusion controlled dissolution regime was imposed at specific crystal 
faces, csurf {hkl}=csat, (Figure 3.11 (b-c)). It can be seen that the surface concentration is 
much larger when dissolution is diffusion-controlled. A first comparison of Figure 
3.11 (a) and (b) indicates how the experimental system evolves towards increasing 
diffusion control with time. This is also highlighted in Figure 3.12, which shows plots 
of the ratio of diffusion to experimental fluxes (JMT/ Jobs) for the different faces versus 
time. JMT1 is the predicted flux for a process where the dissolution of all the crystal 
faces is purely diffusion-limited and Jobs is the measured flux. During the early stages, 
the dissolution rates of the BIC crystal would be at least two orders of magnitude 
higher if dissolution of all the crystal faces was limited by diffusion (MT1 model). 
Whereas at later stages, the magnitude of the experimentally obtained fluxes tend 
towards those calculated for a pure diffusion-limited system (see supporting 
information, section 3.5.1), particularly for the {1¯02} faces, which are those that 
dissolve the fastest. It is important to note, that the flux magnitude is strongly 
influenced by the crystal morphology and size, and under mixed kinetic control, the 
crystal geometry and the BIC concentration at adjacent crystal faces. In the MT1 
model, the concentration of BIC near all the crystal faces is csat, an extreme situation 
that does not take into account the acute anisotropic kinetic character for dissolution 
of the different (hkl) crystal faces observed experimentally (different balance between 
mass transport and surface kinetics for each family of faces, vide supra). Under mixed 
kinetic control, the flux of solute molecules arising from the most morphologically 
important face, the (100) face, affect the apparent behavior of the very small adjacent 
faces. To illustrate this point, a third set of models where only the dissolution of the 
{051} and {1¯02} faces was forced to be diffusion-limited and the slow dissolving large 
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basal (100) face behaved as observed experimentally, were formulated (MT2). In this 
situation, the calculated molar flux of BIC, JMT2 at the {051} and {1¯02} faces is much 
higher than that calculated by MT1 for each dissolution time (Figure 3.12). The kinetic 
regime of these smaller faces is then in good agreement when comparing either 
concentrations near the crystal/solution interface or flux of material (JMT2/ Jobs). 
Further, through this model, one can even appreciate the effect of the influence of the 
concentration near the {051} and {1¯02} faces on the calculation of csurf, (100). This is 
observed to be enhanced compared to that calculated in the experimental model, 
despite the fact that the flux applied was the same in each case, Jobs,(100) = JMT2,(100) as 
shown in the supporting information, section 3.5.1.  
 
Figure 3.11. FEM simulation for the dissolution of a BIC crystal in bulk aqueous 
solution at different time points: (a) model formulated from experimental data. (b) a 
MT1 model where the dissolution of all faces is purely diffusion-controlled; and (c) 
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MT2 model where only the {051} and {1¯02} faces are diffusion-controlled and the 
(100) face dissolves as observed experimentally. Note the difference in the 
concentration ranges for (a) and (b)-(c) 
 
Figure 3.12. Comparative plots of JMT/Jobs versus time for the (100) faces (black), 
{051} faces (red) and {1¯02} faces (blue), showing the extent to which each face 
evolves towards increasing mass transport contribution during dissolution in the case 
where all the crystal faces are diffusion–limited (MT1) and where only the {051} and 
{1¯02} faces are diffusion–limited (MT2). 
 
3.4. Conclusions  
In this study, the combined use of in situ AFM measurements and FEM modeling has 
allowed the surface processes that accompany dissolution to be monitored 
quantitatively in real-time to obtain dissolution kinetics for individual faces of a single 
BIC microcrystal. Morphological changes and the formation of pits associated with 
surface-controlled dissolution were observed. At longer dissolution times, the 
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roughening of individual crystal faces and the exposure of high index faces result in 
greatly increased dissolution kinetics. Incorporating AFM experimental data into a 
FEM model of a dissolving BIC microcrystal has provided direct concentration 
distributions at individual crystal faces. As a result, the importance of surface kinetics 
compared to mass transport for each crystal face was determined. All BIC crystal faces 
showed significant surface kinetic-controlled dissolution behavior, being far from the 
mass transport limited regime, but with increasing mass transport (diffusion) 
contribution to the kinetics as the reaction preceded.  
The study of single microcrystals provides considerable understanding of API crystal 
dissolution kinetics and could provide strategic insight for the future engineering of 
drug crystals with appropriate dissolution characteristics whilst maintaining suitable 
physical and chemical stability. For example, these studies have shown that roughened 
and defect-rich surfaces have greatly enhanced dissolution kinetics. Further, the 
significant time-dependence of the dissolution kinetics is important for improved 
pharmacokinetic modeling.  
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3.5. Supporting Information  
3.5.1. Interfacial Concentration Values 
Table 3.3. Concentration near the crystal/solution interface and normal total fluxes 
at various times for the different crystal faces calculated from FEM simulations.  
 
Time 
 (min)  
Faces 
{hkl} 
Csurf 
Experimental 
(mol m-3) 
Csurf 
MT1 
(mol m-3) 
Csurf 
MT2 
(mol m-3) 
Jobs 
(mol m-2 s-1) 
JMT1 
(mol m-2 s-1) 
JMT2 
(mol m-2 s-1) 
20 100 2.38 × 10-4 1.16 × 10-2 7.02 × 10-3 9.94 × 10-9 6.63 × 10-7 9.94 × 10-9 
20 051 2.68 × 10-4 1.16 × 10-2 1.16 × 10-2 9.27 ×  10-8 2.09 × 10-6 7.52 × 10-6 
20 1¯02 2.04 × 10
-4 1.16 × 10-2 1.16 × 10-2 6.87 × 10-8 3.21× 10-6 8.47 × 10-6 
80 100 3.93 × 10-4 1.16 × 10-2 7.03 × 10-3 1.69 × 10-8 6.98 × 10-7 1.69 × 10-8 
80 051 4.45 × 10-4 1.16 × 10-2 1.16 × 10-2 1.80 × 10-7 2.34 × 10-6 8.84 × 10-6 
80 1¯02 4.01 × 10
-4 1.16 × 10-2 1.16 × 10-2 2.19× 10-7 3.60 × 10-6 9.95 × 10-6 
170 100 9.45 × 10-4 1.16 × 10-2 7.21 × 10-3 3.77 × 10-8 7.24 × 10-7 3.77 × 10-8 
170 051 1.11× 10-3 1.16 × 10-2 1.16 × 10-2 4.88 × 10-7 2.42 × 10-6 8.88 × 10-6 
170 1¯02 1.45 × 10-3 1.16 × 10-2 1.16 × 10
-2 1.25 × 10-6 3.85 × 10-6 1.01 × 10-5 
230 100 1.55 × 10-3 1.16 × 10-2 7.46 × 10-3 6.43 × 10-8 8.62 × 10-7 6.43 × 10-8 
230 051 1.90 × 10-3 1.16 × 10-2 1.16 × 10-2 9.48 × 10-7 2.72 × 10-6 9.35 × 10-6 
230 1¯02 3.42 × 10
-3 1.16 × 10-2 1.16 × 10-2 3.97 × 10-6 4.55 × 10-6 1.10 × 10-5 
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JMT1 = Theoretical flux obtained for when all crystal faces are purely diffusion 
controlled, JMT2 = Flux obtained when only the {051} and {1¯02} faces are purely 
diffusion controlled and the (100) face as observed experimentally and Jobs = 
Experimental flux. 
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Chapter 4  
Functional Multimicroscopy Approach to 
Assess the Dissolution Performance of 
Amorphous Solid Dispersions (ASDs) 
_____________________________________ 
Innovative drug formulations are needed to enhance the solubility and bioavailability 
of poorly soluble active pharmaceutical ingredients (APIs), among which amorphous 
solid dispersions (ASDs) are of increasing interest. However, rapid dissolution from 
the amorphous state poses the risk of competing crystallization from the resulting 
supersaturated solution state. This study considers the physicochemical processes that 
take place during the dissolution of ASDs containing the poorly water-soluble API 
felodipine and the water-soluble polymer, copovidone using a range of techniques, 
some of which have not been applied to this type of problem previously. We have 
compared two different loadings, 15 % and 50 % felodipine by weight. A novel 
electrochemical cell approach is described to induce and monitor API release just 
after immediate contact with water. These studies indicate rapid dissolution fluxes for 
both loadings, but with higher fluxes for the higher loading. These observations are 
complemented with simple optical microscopy, in situ atomic force microscopy and 
Raman spectroscopy to monitor changes in the solid over much larger times. This has 
revealed important phase transformation (crystallization) processes that could 
compete with API release and limit the effectiveness of ASDs. 
  
Chapter 4 
 
97 
 
4.1. Introduction  
Many newly developed drugs with pharmacological activity are characterised by poor 
aqueous solubility and dissolution profiles.1,2 There is thus increasing interest in 
innovative formulations to enhance solubility and bioavailability, including the use of 
nanocrystals, nanoemulsions, polymer micelles and solid dispersions.3-8 This 
contribution concerns solid dispersion formulations,7,9,10 whereby a poorly water 
soluble drug is mixed with a water-soluble polymer carrier, commonly via spray 
drying or hot melt extrusion.11,12 The drug within the dispersion is in the amorphous 
form, giving enhanced solubility and dissolution rates than the corresponding 
crystalline form. Polymer carriers are expected to provide significant stability of the 
amorphous state of the drug (with respect to crystalline forms) in both the solid state 
and in the resulting supersaturated solution generated by dissolution.13,14 However, the 
high free energy of the amorphous form means that reversion to the most stable form 
via recrystallization may occur and has to be assessed. 
Despite their usefulness in improving dissolution rates, marketed products based on 
this strategy are few. The state of the drug in a solid dispersion (i.e. balance between 
the amorphous/crystalline states) is often difficult to characterize due to limited 
available techniques.15,16 In addition, there is a lack of clear understanding of the in 
vivo and in vitro behaviour of ASDs during dissolution. It has been highlighted that 
the mechanism of drug release can be either polymer controlled or drug controlled,17 
and the extent of either pathway is influenced by the physicochemical properties of 
both the active pharmaceutical ingredient (API) and the polymer, as well as the ratio 
between the two. Previously, it has been shown that crystallization of the drug in either 
the solid state or from a supersaturated state in solution (with respect to a crystalline 
form) is critical in understanding the overall dissolution performance.18,19 
Additionally, the formation of nano- and micro- particles in the solid state or during 
dissolution has been shown to contribute to the dissolution mechanism.20      
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The addition of water to ASDs has many phenomenological effects, particularly when 
the API (drug) is poorly water-soluble and the polymer is hydrophilic, as is usually the 
case.21-23 Water addition may drive the system towards polymer-drug phase separation 
creating two domains; one rich in polymer and the other rich in drug.24-26 The resulting 
low polymer content in the drug rich domain can lead to phase transformation causing 
crystallization to occur, which would hinder the overall dissolution performance. This 
known phenomenon of amorphous-amorphous phase separation is not fully 
understood as is affected by many variables including drug-polymer interaction 
strength, drug and polymer properties, as well as the drug-polymer ratio.13,25,27,28 
Conventional methods for studying API release do not readily probe phase transitions 
that might occur during dissolution and so the development of more incisive 
techniques could be valuable in enhancing mechanistic information. In this study, the 
ASD of interest comprises felodipine drug in a water-soluble polymer, copovidone 
VA64 (Scheme 1). Felodipine is a calcium-channel blocking agent, widely used for 
treatment of hypertension.29 In previous studies, the dissolution performance of ASDs 
containing felodipine has been shown to be highly dependent upon drug loading13,30-34 
and so in this study two different drug loadings were investigated, 15 % and 50 %. 
With a combination of in situ atomic force microscopy (AFM), Raman spectroscopy 
analysis and an electrochemical cell probing technique, it was possible to observe key 
features in the mechanism and kinetics of drug dissolution in aqueous solution, with 
results that highlight the importance of drug loading on the dissolution of ASDs. An 
advantage of this approach is that we are able to follow crystallization at a much 
smaller length scale, and in some cases shorter timescale, than has been possible 
previously. 
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Scheme 4.1. Molecular structures of (a) felodipine and (b) copovidone. 
 
4.2. Experimental Section 
4.2.1. Solutions and Sample Preparation 
All chemicals were used as received. Aqueous solutions were prepared using high 
purity water (Purite, Select HP) with a resistivity of 18.2 MΩ cm at 25 °C. Polymeric 
dispersions of felodipine were supplied by AstraZeneca. 
4.2.2. Optical Microscopy 
Optical observations utilized a 20X objective lens on a Leica DM4000 M compound 
microscope.  
4.2.3. In situ Atomic Force Microscopy 
Dissolution studies were performed in unstirred solution directly in a petri dish (Willco 
Well) containing the polymeric dispersions of interest fixed to the surface by double 
sided tape, using a Bioscope Catalyst microscope with a Nanoscope V controller 
(Veeco). AFM images were acquired in ScanAsyst mode using silicon-tips on a silicon 
nitride lever with a spring constant of 0.35 Nm-1 according to the manufacturer (SNL-
10, Bruker).  
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4.2.4. Raman Spectroscopy  
In situ Raman investigations were performed on a Renishaw inVia Reflex Raman Microscope 
fitted with a Charge Coupled Device (CCD) detector with a near-IR (633 nm) laser. A 20X 
objective lens was used for images presented herein. 
4.2.5. Quad-Probe Fabrication 
Quad-probes (pipettes containing 4 channels) were fabricated from quartz quadruple-
barrelled capillaries (MBT-015- 062-4Q, Friedrich & Dimmock, Inc.) pulled to a sharp 
point by a laser puller (P-2000, Sutter Instruments) as described in chapter 2 and in 
detail elsewhere.35 After pulling, the end of each channel was ca. 400 nm across. Two 
of the channels were filled with carbon by pyrolysis of butane gas passed though these 
channels simultaneously as described previously.35 The probes were then further 
optimized by focused ion beam (FIB) polishing to achieve a final probe size of ca. 2 
µm diameter across. FIB-SEM (JEOL 4500, JEOL) at an accelerating voltage of 5 kV 
with gallium ions was used. The empty channels were each filled with 100 mM KCl 
solution together with a AgCl-Ag wire to act as a quasi-reference counter electrode 
(QRCE). A home built scanning electrochemical cell microscope with home built 
current follower was used as described elsewhere.35 
4.2.6. Electrochemistry 
Some control electrochemical measurements were made to determine whether 
felodipine could be detected electrochemically. Measurements utilised 5 mm glassy 
carbon (GC) electrode. Gamry Instruments rotating electrode equipped with motor 
controller was used that enabled a precise mass transport rate to be applied. A 3 
electrode set-up was employed with a Pt counter electrode and Ag/AgCl wire reference 
electrode. Measurements used a CHI Instruments potentiostat controlled by a PC.   
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4.3. Results and Discussion  
4.3.1. Optical Microscopy  
The behaviour of polymeric matrices of copovidone containing different loadings of 
felodipine 15 and 50 % w/w, were first monitored immediately after adding ultrapure 
water (2 mL) using optical microscopy. Figure 4.1, shows images of the two ASD 
formulations, as solids, before and after contact with water. Figure 4.1 (a) (i) shows an 
optical image taken before the addition of water to the formulation containing 15 % 
felodipine and Figure 4.1 (a) (ii) is taken after water contact. Here, we observe the 
formation of a gel-like swollen layer, as a consequence of the plasticization of the 
polymer by the water.36 This is due to the relatively high content of polymer in the 
formulation, such that the characteristics are dominated by the hydration of the 
polymer to form a gel. In stark contrast, the formulation containing 50 % felodipine, 
illustrated in Figure 4.1 (b) (i) and (b) (ii) showed little change upon water contact (on 
the resolution of optical microscopy). These brief observations highlight distinct 
differences in the behaviour of these formulations, which we now investigate with 
different type of advanced microscopy.  
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Figure 4.1. Optical microscope images taken before and after the addition of water 
to the two formulations of amorphous solid dispersions. (a) 15 % felodipine ASD and 
(b) 50 % felodipine ASD (i) represents dry sample and (ii) when in contact with water.  
 
4.3.2. Topographical Changes: In situ Atomic Force Microscopy Analysis  
For further insight into the phase transformations taking place upon water contact with 
the ASDs, we turned to in situ AFM. Due to the polymer plasticization effect seen with 
the 15 % felodipine ASD, AFM measurements proved difficult. However, it was 
possible to monitor the aqueous dissolution of the 50 % felodipine ASD over time, 
shown in Figure 4.2. Examining Figure 4.2, as the dissolution process proceeded, AFM 
images show the formation of nanoparticles, a few 10s nm in size, on the surface of 
the solid ASD on a fairly long timescale of several hours. As discussed in the next 
section, this behaviour in the solid state correlates with the crystallization of the 
felodipine in the solid state on this time scale.  
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4.3.3. Raman Spectroscopy  
In situ Raman studies were carried out on the two ASDs (15 and 50 % w/w). Figure 
4.3 (i) shows the evolution of the Raman spectra for the two ASDs after contact with 
water.  For comparison, the Raman spectrum of crystalline felodipine was acquired in 
air and is represented by the red trace. It is characterized by sharp peaks at 1206 cm-1, 
1484 cm-1 and at 1650 cm-1. Comparison with the dry ASD shows that there is a 
characteristic copovidone peak at 1431 cm-1. Figure 4.3 (a) (i) shows the Raman 
spectra of the 15 % felodipine ASD as a function of time. Over time, there is a 
reduction in intensity of the copovidone peak at 1431 cm-1, as well as the felodipine 
peaks at 1650 cm-1 and 1484 cm-1 as shown in Figure 4.3 (a) (ii) and (iii). This agrees 
with the Raman studies of Tres et a.l for a 5 % felodipine extrudate,37 suggesting that 
felodipine and copovidone dissolve at a similar rate, as a single entity rather than as 
two separate components. However, the spectrum recoded after 24 hours shows a 
decrease in intensity of the felodipine peak at 1484 cm-1 relative to the copovidone 
peak at 1431 cm-1 signifying some recrystallization of the amorphous felodipine. In 
addition, characteristic felodipine peaks at 1650 cm-1 and 1206 cm-1 intensify at this 
time point.37 
For comparison, Figure 4.3 (b) (i) shows the Raman spectra of the 50 % ASD during 
dissolution. After four hours, the intensity of the copovidone peak at 1431 cm-1 
decreases as the felodipine peak at 1484 cm-1 increases slightly, as represented in 
Figure 4.3 (b) (ii). This effect is seen even more after long times (42 hours), in which 
felodipine peak at 1650 cm-1 also increases in intensity (Figure 4.3 (b) (iii)). As a 
consequence, amorphous felodipine material in the solid state recrystallize due to the 
dissolution of copovidone. After 42 hours, the Raman spectrum of the dispersion 
resembles the crystalline felodipine spectrum, confirming the recrystallization of the 
initial amorphous felodipine.                     
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Figure 4.2. Series of in situ AFM images over time showing the recrystallization of 
felodipine during the aqueous dissolution of 50% felodipine ASD.  
 
Figure 4.3. Raman spectra relative to the aqueous dissolution of: (a) (i) 15% 
felodipine and (b) (i) 50% felodipine ASD over time. Spectrum in red 
highlights Raman signal of crystalline felodipine for comparison. (b) (ii) (iii) 
show the peak height intensity of amorphous felodipine  and copovidone as 
a function of time. 
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4.3.4. In situ Electrochemical Monitoring of Initial Dissolution 
Hitherto, we have focused on the analysis of the solid ASDs during dissolution, but 
we are ultimately interested in the release of the soluble drug. We now present 
electrochemical techniques to monitor initial dissolution from the ASD phase. Firstly, 
to examine the electroactivity of felodipine, bulk electrochemical measurements were 
performed. Rotating disk electrode voltammetry was recorded on glassy carbon in 
solution containing known concentration of felodipine (3 µM) in 100 mM KCl with 
representative cyclic voltammogram (CV) shown in Figure 4.4. A diffusion-limited 
current response was obtained using glassy carbon at electrode rotation speed of 2000 
rpm showing the clear electro-oxidation of felodipine. We then moved onto the use of 
the carbon quad probes. To test the electrode (~10 µm diameter), the one-electron 
electro-oxidation of 1 mM (ferrocenylmethyl) trimethyl ammonium (FcTMA+) was 
performed. Figure 4.4 (b) shows the acquired CV resulting in a steady-state current 
response resembling the behaviour of ultramicroelectrodes (UMEs)38’
39 and signifying 
the good functionality of this electrode. Thus, the carbon quad probe was used to detect 
the electro-oxidation of felodipine. Figure 4.4 (c) show a CV run at 100 mVs-1 in 
saturated solution of felodipine (~49 µM) 40. A clear limiting current is observed. In 
order to confirm that this is the correct electrode response, we compared our results to 
the theoretical current (~0.045 nA) where the diffusion coefficient of felodipine 
molecules in aqueous solution (D = 4.15 × 10-6 cm2 s-1) was calculated using the Wilke-
Chang equation.41 This provides diffusivities with an absolute error no bigger than 
11%. Accordingly, the current magnitude achieved herein (~0.06 nA) is within good 
proximity.  
Theoretical current was calculated from the acquired data shown in Figure 4.4.   Firstly 
the Levich equation was used to calculate the number of electrons transferred during 
the oxidation of felodipine using RDE. Here, 𝑖𝑙𝑖𝑚 is the limiting current, n is the 
number of electrons transferred, F is the Faraday constant (96485 Cmol-1), A is the 
electrode area (cm2), D is the diffusion coefficient (cm2s-1), ω is the angular rotation 
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rate of the electrode (rads-1), 𝑣 is the kinematic viscosity (cm2s-1), C is the 
concentration (molcm-3).  
𝑖𝑙𝑖𝑚 = 1.554𝑛𝐹𝐴𝐷
2
3𝜔
1
2𝑣−
1
6[𝐶]                                    (1)                                     
Using the limiting current achieved of the oxidation of 3 µM felodipine on 5 mm glassy 
carbon (Figure 4.4 (i)), n was calculated:  
𝑛 =  
1.8×10−7
1.554×96485×0.196×(2.58×10−4)×5.77×2.15×(3×10−9)
  
𝑛 = 0.64 ~1 electron 
Following on, the oxidation of 1 mM FcTMA+ was carried out on carbon quad barrel 
(Figure 4.4 (ii)). Using equation (2) the radius, 𝑎 of the carbon quad electrode was 
calculated:  
                            𝑖 = 4𝑛𝐹𝐷𝑎𝐶                                    (2) 
𝑎 =  
1.4×10−9
4×1×94685×(6.3×10−6)×(1×10−6)
  
𝑎 = 5.76 × 10−4 𝑐𝑚 ~ 5.76 µ𝑚  
The rate constant, 𝑘 was calculated using equation (3) and the theoretical current was 
achieved using equation (4): 
                                       4𝑎 = 𝑘                                       (3) 
                                   𝑖 = 𝑘𝑛𝐹𝐷𝑐                                 (4) 
(2.3 × 10−3) × 1 × 96485 × (4.149 × 10−6) × (4.9 × 10−8) = 0.045 nA   
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Figure 4.4. (a) Rotating disk electrode voltammogram run on glassy carbon electrode 
of  3 µM felodipine solution containing 100 mM KCl. (b) Shows the current response 
of a carbon quad probe (~10 µm diameter) in 1 mM FcTMA+ containing 100 mM KCl. 
(c) CV of saturated felodipine solution containing 100 mM KCl at 100 mVs-1. 
 
The application of UMEs to study dissolution is established.42-44 By positioning a 
UME close to the surface of interest crystal dissolution can be induced and monitored. 
Here, similarly, we present the use of a droplet-based electrochemical technique that 
uses a liquid droplet formed at the end of quad probe pipette with open fluid channels 
and integrated carbon electrodes, to create an electrochemical meniscus cell on the 
sample surface.45-47 At a potential for the diffusion-limited detection of felodipine, the 
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current recorded at the carbon electrodes (sink conditions) is proportional to the 
dissolution flux which can be used to measure the rate of release of material from a 
surface. 
As mentioned in the experimental section, the two open barrels are filled with 
electrolyte (100 mM KCl) and equipped with QRCEs (Ag/AgCl wires) and the other 
two were carbon working electrodes.35 The basic approach to the use of a quad probe 
to locally measure dissolution of the polymeric dispersions is shown in the cartoon 
illustration in Figure 4.5 (a). The probe was brought vertically towards the substrate to 
make meniscus contact with a fresh solid surface to form a thin layer electrochemical 
cell between the probe and surface (typically 1µm thickness or less).35 Figure 4.5 (b) 
(i) shows, a scanning electron micrograph of the end of a typical probe used to give an 
idea of scale, and an optical side view of the probe positioned close to the sample 
surface is shown in Figure 4.5 (b) (ii). 
 Figure 4.5 (c) (i) and (ii) show typical voltammograms for the detection of felodipine 
from the two ASDs. The lower drug loading ASD (15 % felodipine) resulted in a lower 
currents compared to the higher drug loading (50 % felodipine), as much more 
felodipine is detected due to induced dissolution. Note that, the current values achieved 
herein are much higher than would be expected for the aqueous solubility 
concentration of felodipine (~49 µM) in a bulk solution. By sweeping the potential of 
the carbon very close to the surface (i.e. under very strong sink conditions) we induce 
dissolution resulting in high current values. These observations indicate that ASD 
formulations indeed provide a technology for rapid drug release.  
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Figure 4.5. (a) Schematic of the electrochemical quad-probe. The probe moves down 
so that the meniscus is in contact with the amorphous solid surface. Carbon 
electrodes detect the release of felodipine upon water contact and the QRCEs in the 
open barrels in the probe act as the reference/counter electrodes. (b) (i) SEM 
micrograph of the end of a typical quad-probe showing carbon electrodes (top and 
bottom) and open barrels (left and right). (ii) Optical microscope image of the probe 
tip positioned above a single solid before landing. (c) (i) Current-potential response 
recorded at the quad-probe during approach and after the meniscus came into 
contact with the surface of the ASD containing (a) 15 % felodipine and (b) 50 % 
felodipine.  
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4.4. Conclusions  
We have demonstrated the use of a multi-microscopy approach to locally probe the 
dissolution process of amorphous solid dispersion in real time. With Raman 
spectroscopy of the ASD, we were able to track the dissolution of both the API and 
polymer simultaneously. For both ASDs, recrystallization of felodipine was observed 
but it was much more noticeable for the 50 % ASD where the Raman signal at longer 
times showed strong crystalline felodipine characteristics. This was further shown by 
in situ AFM studies, where changes in topography were tracked over time and 
formation of particles on the surface was observed. In addition, at much shorter 
timescales, carbon quad probes were used to induce the dissolution of ASDs, proving 
that rapid release of felodipine occurs under steady sink condition.  
These brief studies demonstrate the importance of drug/polymer ratio in controlling 
the dissolution behaviour in ASD formulations. We have also shown the value of 
microscopy approaches, some of which are not widely used in pharmaceutical science, 
but offer considerable potential to improve understanding of complex dissolution 
processes.   
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(47) Snowden, M. E.; Güell, A. G.; Lai, S. C. S.; McKelvey, K.; Ebejer, N.; O’Connell, 
M. A.; Colburn, A. W.; Unwin, P. R. Analytical Chemistry 2012, 84, 2483-2491. 
 
 
 
Chapter 5 
 
115 
  
Chapter 5  
Confined Crystallization of Organic Materials 
in Nanopipettes: Tracking the Early Stages of 
Crystal Growth and Making Seeds for 
Unusual Polymorphs 
_____________________________________ 
Monitoring crystallization in real time at the nanoscale can provide valuable new insights into 
the nucleation process. Herein, the application of nanopipettes as nanoreactors to study the 
nucleation of organic materials (pharmaceutical crystals) is demonstrated, using 
bicalutamide (BIC), an active pharmaceutical ingredient of the prostate cancer drug 
CASODEX®, as a model. Crystallization is achieved using a nanoscale antisolvent system, 
whereby a nanopipette containing an aqueous inert salt solution is brought into contact with 
a dimethyl sulfoxide (DSMO) solution containing soluble BIC and the same inert salt (at the 
same concentration). Crystallization is driven and controlled by a combination of the applied 
bias between an electrode in the nanopipette and one in the bulk DMSO phase and mixing of 
the two solvents at the mouth of the nanopipette. Crystallization at the tip of the nanopipette 
causes transient blockages, as BIC particles form and translocate at the end of the nanopipette 
opening. At low inert electrolyte concentration, the current-time signature is highly stochastic 
and comprises a sequence of current pulse increases and decreases, which could either 
indicate nucleation-dissolution during phase transformation, and/or be due to the particles 
formed being charged. Particles produced in this way can be used as seeds for crystal growth 
and Raman spectroscopy analysis of the crystals produced indicates the formation of Form II 
BIC which is rarely formed. Thus, in addition to monitoring nucleation, nanopipettes can serve 
as reactors to synthesize organic crystals with polymorphs that are not typically found. Finite 
element method modeling provides valuable insight on the solvent mixing process and effect 
of applied bias, and helps to explain some of the observations. This work is published in 
Crystal Growth & Design.
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5.1. Introduction 
Crystallization at the nanoscale, in a confined environment, can have a significant 
impact on the properties of the emerging crystal structure, including the formation of 
unusual metastable polymorphs.1  
When compounds are capable of exhibiting polymorphism, the free energy profiles of 
the different polymorphs will determine the final crystal structure, shown in Figure 
5.1. As polymorphs have different crystal structures, their specific surface energies, 
volume free energies, and crystal morphologies will differ. Accordingly, each 
polymorph will have distinct ∆G and critical nucleus size. Figure 5.1 illustrates free 
energy profiles in which polymorph B is more stable in bulk form but polymorph A is 
more stable at the critical size and slightly beyond. Thus, suggesting that crystallization 
in confined environments with dimensions at or near the critical size could lead to 
stabilization of metastable polymorphs (i.e. size-dependent polymorphism). As a 
result, confinement provides an alternative method for controlling polymorphism.  
 
Figure 5.1. Schematic representation of the free energy profiles for two 
competing nuclei corresponding to polymorphs A and B, over a range of 
sizes. 
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Herein, nanopipettes are shown to provide a powerful methodology for detecting the 
nucleation and growth of seeds of pharmaceutical crystals, using bicalutamide (BIC) 
(shown in scheme 5.1), as an exemplar system. BIC is an active pharmaceutical 
ingredient (API) in AstraZeneca’s prostate cancer product CASODEX®, belonging to 
class II of the biopharmaceutics classification system (BCS) (low solubility and high 
permeability).2, 3 It has received considerable attention as a model for class II drugs.4-
6 Crystal polymorph control is an important aspect of drug formulation, to ensure 
bioavailability and stability of the drug product. Unusual polymorphs may provide a 
route to enhancing solubility of class II biopharmaceutics,1, 7 and an aspect of this paper 
is the creation of polymorph II of BIC rather than the more stable polymorph I that is 
usually formed. 
Nanopipettes and solid state nanopores, have become established as powerful tools in 
the detection and manipulation of single entities (nanoparticles and macromolecules) 
through the use of resistive pulse principles.8-15 As an entity translocates through a 
pore connecting two electrolytic solutions (for example between the inside and outside 
of a nanopipette), with an applied bias, resulting changes in the ionic current can 
provide information about the size and surface properties of the entity, as well as its 
speed of translocation.11, 16, 17 Typically, the presence of an insulating particle in the 
orifice of a pore causes a transient increase in the pore resistance (decrease in the ionic 
current), 10, 17-19 the magnitude of which informs on the particle size. 
Nanopipettes, are particularly attractive for resistive pulse experiments, as they can be 
prepared easily and rapidly from quartz or glass capillaries to give a range of tuned 
orifice sizes, usually of conical geometry, simply by adjusting the laser puller 
parameters.19-23 The conical shape of the nanopore has potential benefits in that the 
electric field is greatest at the opening, where the nanopipette becomes narrower, 
providing a higher sensitivity for resistive pulse sensing.22 Consequently, applications 
of nanopipettes are expanding apace.24-26 Of relevance to the studies herein, the use of 
nanopipettes as reaction centers for monitoring the nanoscale crystallization of zinc 
phosphate has been described.27 While applying a voltage bias across the nanopipette 
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opening, current oscillations were observed that were attributed to the precipitation 
and dissolution of zinc phosphate in the nanopipette opening. With precursor zinc and 
phosphate salts, one in the nanopipette and the other in the bathing solution, it was 
demonstrated that the sign of the applied bias could be used to drive either 
crystallization or dissolution at the nanopipette opening. We recently used this 
methodology to monitor the crystallization and dissolution of calcium carbonate in 
nanopipettes and showed this to be a powerful platform for rapidly screening crystal 
growth additives.28 Additionally, the formation of inorganic salt nanoparticles in 
conical nanopores has been reported.29-31 
The above examples have considered aqueous crystallization, but some work  in much 
larger pores, in borosilicate glass or silicon nitride, have considered the use of different 
solvents either side of the pore mouth (solvent/antisolvent system), which mix at the 
pore to produce a supersaturated solution.32 This is the type of system considered 
herein, but with the use of much smaller pores (50 nm diameter) formed using glass 
nanopipettes as illustrated in Figure 5.2.  
 
Figure 5.2. Schematic showing the crystallization of bicalutamide in a 
nanopipette.  
Studies on this dimension are especially interesting because unusual polymorphs 
might be expected, due to the dramatic size-dependent stability properties of 
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polymorphs on this length scale.33 With the use of finite element method (FEM) 
modeling, insight is provided into the solvent mixing phenomenon that leads to 
precipitation and the strong effect of applied bias that is observed. These new studies 
suggest that nanopipettes are potentially very useful devices for monitoring the 
nucleation of crystals in an antisolvent system and creating seeds for unusual 
polymorphs.  
 
 
Scheme 5.1. Molecular structure of bicalutamide. 
 
5.2. Experimental Section  
5.2.1. Materials and Solutions 
For all experiments, unless stated otherwise, the nanopipette contained 100 mM 
tetrabutyl ammonium chloride (TBA+Cl-), from Sigma-Aldrich, in ultrapure water 
(Purite, Select HP) of resistivity 18.2 MΩ cm (at 25 ºC). The bath solution consisted 
of dimethyl sulfoxide (DMSO, Fisher, purity 99.7%) solution containing 100 mM 
TBA+Cl- and 5 mM BIC. Solid crystalline BIC was kindly supplied by AstraZeneca.   
5.2.2. Nanopipettes  
Nanopipettes were fabricated from quartz capillaries, with an outer diameter of 1.00 
mm and an inner diameter of 0.5 mm (Friedrich and Dimmock). Using a laser puller 
(P-2000, Sutter instruments), capillaries were pulled to give a nanopipette with an 
opening diameter of approximately 50 nm at the end and semi-angle that over a few 
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microns from the end approximated to ca. 3.7˚. Several pulled pipettes were examined 
by transmission electron microscope (TEM) to confirm these dimensions were 
consistent.23, 34, 35  
5.2.3. BIC Crystallization Measurements  
A two-electrode setup was employed with a AgCl-coated Ag QRCE inserted into a 
nanopipette filled with aqueous TBACl solution and a second similar QRCE was 
placed in the bulk DMSO solution. The current, I, was measured as a function of time 
with the potential, V, applied in a defined way (constant or linearly scanned with time), 
using a home-built potentiostat and electrometer. Potential control and data acquisition 
was achieved using an FPGA card (7852R, National Instruments) controlled by a 
LabVIEW 2013 interface, National Instruments. All measurements were made at 23 ± 
1 °C. The potential of Ag/AgCl electrode in DMSO was monitored over time and was 
found to be stable as represented in Figure 5.3. This gives an idea of the overall 
equilibrium potential difference between the 2 electrodes in the experimental set up, 
which is small and close to zero compared to the applied potentials. The AgCl-coated 
Ag wire functions as a stable electrode in many aqueous media.28, 36-39 
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Figure 5.3. Using the same experimental setup as shown in Figure 5.4 and having no 
BIC in the bath solution, the stability of the Ag wire-coated Ag/AgCl in DMSO was 
measured by recording the potential of the electrode over time. 
 
5.2.4. Raman Spectroscopy 
Raman microscopy investigations of individual crystals employed a Renishaw inVia 
Reflex Raman Microscope fitted with a Charge Coupled Device (CCD) detector with 
a near-IR (633 nm) laser. A 50 objective lens was used. 
 
5.2.5. Finite Element Method Simulations 
Finite element method (FEM) simulations were carried out to understand the mixing 
zone of the two solvents and extract saturation levels of BIC near the mouth of the 
nanopipette. These simulations were done using COMSOL Multiphysics 5.2a using 
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the transport of diluted species and electrostatics modules. Simulations used a 2D 
axisymmetric cylindrical geometry. The simulation domain, diffusion coefficients and 
boundary conditions are presented in the supporting information, section 5.5. Briefly, 
mixing of the solvents was treated as a diffusive process, given the nanoscale 
dimensions of the system40, with bulk concentration of 55 M water initially inside the 
pipette and 14.1 M DMSO in the bulk solution. The simulations accounted for the 
dependence of the diffusion coefficient of H2O and DMSO on the H2O: DMSO ratio 
(see supporting information, section 5.5.2.), but for simplicity assumed no changes in 
the solution density (volume) in the mixing zone, so that a Newtonian fluid model 
could be assumed. The density and volume of mixed H2O: DMSO solutions is known 
and was reasonably assumed no density or volume changes. For a mole fraction of 
water up to 0.65 which applies to most of the nanopipette tip, the density (and volume) 
of solutions is very similar to that of water.41,42 Although molar enthalpy is negative 
for H2O, DMSO mixing,43 the value is moderate, and due to the rapid mixing of 
solvents, and the nanoscale mixing zone in the tip, the temperature was considered to 
be constant. 
100 mM TBA+Cl- was present inside and outside the pipette, with 5 mM BIC in the 
bath solution. Simulations considered several different applied biases, of relevance to 
the experiments. Saturation levels of BIC at different spatial locations were calculated 
based on the local proportion of water to DMSO, and measured saturation levels, as 
shown in table 5.1 acquired from UV-Vis. All UV-Vis spectra were recorded in 
continuous mode with Jasco V-660 spectrophotometer for a range of DMSO: H2O 
mixtures and different BIC concentration values, to produce calibration plots from 
which the BIC solubility could be determined in each case. UV-Vis spectra of BIC 
dissolved in different ratios of DMSO: H2O solutions, represented in Figure 5.4 (a-g) 
(i) UV-Vis spectra of different concentrations of BIC in different compositions of 
DMSO: H2O mixtures. (a-g) (ii) Linear fit showing peak absorption acquired from (i) 
versus BIC concentration. (a-g) (iii) Spectra recorded in different compositions of H2O 
and DMSO containing BIC at the saturated concentration, with the solution then 
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diluted by the factor indicated as an inset. Using the linear calibration fits of 
absorbance versus concentration for each ratio represented in (a-g) (ii), the 
concentration value that corresponded to the acquired absorption point for all the 
different compositions were obtained, represented by the green asterisk, from which 
the BIC solubility values shown in Table 5.1 were obtained.   
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Figure 5.4. UV-Vis spectra of BIC dissolved in different ratios of DMSO: H2O solutions. 
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Table 5.1. Solubility concentrations of BIC 
 
 
 
 
 
 
 
 
 
 
 
5.3. Results and Discussion  
5.3.1. Crystallization of Bicalutamide in a Nanopipette  
A schematic of the typical experimental setup for monitoring BIC nucleation and 
growth events is depicted in Figure 5.5. As mentioned above, the nanopipette was 
filled with 100 mM TBA+Cl- dissolved in water, and this was placed in a bath 
consisting of 5 mM BIC and 100 mM TBA+Cl- dissolved in DMSO. Note that for many 
of the experiments the concentration of BIC used (5 mM) was much lower than the 
saturation concentration in pure DMSO (200 mM), but occasionally different 
concentrations were used, as stipulated herein. A bias applied between the QRCE in 
the nanopipette and one in bulk solution generated an ionic current that could be used 
to monitor changes in the resistance at the end of the nanopipette. When a bias of -0.3 
Volume ratio (DMSO : H2O) Solubility concentration (mM) 
95:05 103 
90:10 78 
85:15 47 
80:20 43 
60:40 4.8 
50:50 3.7 
20:80 0.14 
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V was applied to the nanopipette electrode, transient current blockages (current 
decreases) were observed in the current-time (I-t) trace, as shown in Figure 5.6 (a) (i). 
These events, which have a frequency of 8 ± 1 s-1 (vide infra), are attributed to the 
formation of BIC crystals near the end of the nanopipette, causing an increase in the 
system resistance and decrease in the ionic current. A zoom view of one of the events 
(Figure 5.6 (a) (ii)) shows that they are relatively slow (ca. 100 ms), with a very sharp 
decrease in current, followed by a slower recovery to the nanopipette open state 
current. Experiments performed with different biases revealed that these events 
exhibited a dependence on the applied bias. Figure 5.6 (b) and (c) show samples from 
I-t traces performed with applied bias of -0.1 V and -0.5 V. With increasing bias, a 
higher frequency of blockage events was observed.  
 
Figure 5.5. Setup (not to scale) for voltage dependent nucleation of BIC in conical 
nanopipettes. A bias was applied between an electrode in a nanopipette containing 
aqueous electrolyte and an electrode in DMSO solution containing BIC. The current 
response was measured as a function of time and applied potential. 
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Figure 5.6. Current-time response with 5 mM BIC in the DMSO bath at different 
potentials applied to the tip with respect to the Ag/AgCl electrode in bulk: (a) (i) -0.3 
V, with inset (ii) showing expanded view of highlighted event; (b) -0.1 V; and (c) -0.5 
V. 
 
To confirm that the blockage events were due to BIC, the I-t and current-voltage (I-V) 
behavior were also recorded in cases where 0 mM and 200 mM BIC was present in 
the bath DMSO solution. Figure 5.8 (a) (i) shows example I-t data for a tip bias of -0.3 
V for the case where no BIC was present in the bath solution. Under these conditions, 
a featureless, steady I-t trace was observed, with no transient blockages, suggesting 
that the nanopipette remained in its open state throughout. The open state current is 
ca. -150 pA, broadly similar to the open state in Figure 5.6 (a) (i), recorded with a 
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different nanopipette. Likewise, the I-V curve in Figure 5.8 (a) (ii) shows the 
rectification characteristics expected for a small tip of this size,44 that have negatively 
charged walls.45-47 
With the same nanopipette electrode bias of -0.3 V, but higher concentration of 200 
mM BIC in the DMSO phase (Figure 5.8 (b) (i)), a very high frequency of blockages 
was observed, manifested as an oscillating current between the open and blocked state. 
In fact, the frequency of events is so high that a fully open state current is never 
achieved. At 10 mM and 20 mM BIC in the DMSO solution the event frequency was 
4.1 ± 0.2 and 8.2 ± 0.4 min-1, respectively (data provided in Figure 5.8). These data 
indicate that the frequency of events is strongly dependent on BIC concentration in the 
DMSO phase.   
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Figure 5.7. Current-time response at 0.3 V with different concentrations of 
BIC in the DMSO bath; 5mM, 10 mM and 20 mM. Shown are 3 sets of 
repeats (i-iii) for each concentration. 
 
The I-V measurements presented in Figure 5.7 (b) (ii) further reveals the effect of 
applied bias on the blockage behavior. At negative tip potentials with 200 mM BIC in 
DMSO, rapid blockage and clearance events to an open state are observed, but such 
behavior is not seen at positive tip potentials or in the case where no BIC is present 
(Figure 5.7 (a) (ii)).  
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Figure 5.8. Current-time response at a nanopipette electrode potential of -0.3 V for: 
(a) (i) no BIC in DMSO and (b) (i) 200 mM BIC in DMSO. Corresponding I-V curves of 
each nanopipette prior to current-time measurements are shown in (a) (ii) and (b) 
(ii). 
 
Nanoprecipitation events observed herein are driven predominantly by the antisolvent 
effect48 due to the poor solubility of BIC in water (11.6 µM).4 Based on our 
experimental observations, proposed is that the DMSO and water phases mix locally 
and rapidly (vide infra) at the nanopipette opening. This mixing leads to  the 
protonation of BIC by water, as BIC has a pKa of 12,5 as illustrated in Figure 5.9. 
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Consequently, at negative nanopipette electrode biases, protonated BIC (positively 
charged) will be driven into the body of the nanopipette by the applied electric field, 
but the high-water content of the mixed phase at the end of the nanopipette (vide infra), 
means that the solution becomes locally supersaturated with respect to BIC and 
nucleation occurs. Particle formation (and growth) causes a transient increase in the 
system resistance and blockage of the ionic current. In contrast, in the case where a 
positive tip bias was applied, no blockage events were seen, consistent with protonated 
BIC being largely excluded from the nanopipette opening. Thus, the applied bias has 
a significant effect in promoting or inhibiting crystallization, even though the two 
solvents presumably mix to similar extents irrespective of the bias.     
The blip responses observed, suggest a process where BIC particles form (leading to a 
decrease in the ion conductance current) and subsequently either translocate out of the 
pipette orifice or move further up the conical pipette whose dimensions get wider, re-
establishing the baseline open-state conductance current. It has previously been shown 
that the surface charge of a translocating particle can have an impact on the shape of 
the resistive pulse and is strongly influenced by the concentration of supporting 
electrolyte used.11, 49, 50 High electrolyte concentration screens the charge on the 
particle and the nanopipette walls (short Debye length) and so particle charge has little 
effect, whereas at low electrolyte concentration the Debye length is larger. To explore 
this aspect, I-t measurements were performed with a lower electrolyte concentration 
(10 mM TBA+Cl-), with some example data shown in Figure 5.10. In these instances, 
the transient shape is more complicated showing both an increase resistive pulse, 
described above, but accompanied by an increase in conductance state at some times 
in an overall “event”. These features are broadly similar to features seen on charged 
particles49-53 although in the case of Figure 5.10, the features are much more complex 
and could also result from some repetitive nucleation and redissolution events in the 
growth of a particle (e.g. transformation from one solid phase to another via a solution-
mediated process). Additionally, these events are somewhat slow for a particle 
translocation event,49 and would suggest that the particle, and evolving entity, rattles 
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in the end of the pipette before leaving the reaction zone. Based on the fact that BIC is 
protonated in the aqueous phase, the surface charge of the particle is likely to be 
positive. In this case, the particle would be expected to migrate into the nanopipette 
(given the applied field) but, as we show below, some particles evidently leave the 
nanopipette, perhaps due to physical flow of the more dense aqueous phase into the 
DMSO phase, which is not considered in the simplified model that is presented below.     
 
 
Figure 5.9. Water-DMSO mixing near the mouth of the nanopipette and the 
subsequent transfer and protonation of BIC in the water phase. 
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Figure 5.10. Current-time response at a nanopipette electrode potential of -0.3 V 
using 10 mM TBA+Cl- in each phase and 5 mM BIC in the DMSO phase. Expanded 
views of highlighted events (1-3) are shown. 
 
In order to estimate saturation levels of BIC inside a nanopipette, time-dependent FEM 
simulations were performed with 100 mM TBA+Cl- in the nanopipette (water) and bath 
DMSO solutions. 5 mM BIC was present in the bath solution at the start of the 
simulation. BIC had neutral charge in the bulk organic phase and became protonated 
in the aqueous phase, as shown in Figure 5.9. 
Figure 5.11 presents profiles that show of how the concentrations of water and DMSO 
in the end of the nanopipette, as well as the local saturation level of BIC, varies with 
time after immersing a nanopipette (aqueous solution) into a bath (DMSO). A bias of 
-0.3 V was applied to the nanopipette electrode. It can be seen that the water 
concentration towards the end of the pipette decreases from the bulk value, as water is 
transported out of the nanopipette into the DMSO phase. The DMSO concentration, 
on the other hand, can be seen to propagate up the length of the pipette with increasing 
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time as DMSO diffuses into the pipette. The diffusion of BIC into the nanopipette, 
together with the higher concentration of water, results in the solution becoming highly 
supersaturated with respect to BIC, with extreme saturation levels (Ω = [BIC]total / 
[BIC]sat) of up 140, which is the reason why the crystallization process is so driven. It 
can be seen that quasi-steady profiles are produced at times between 10 ms and 100 
ms.  
 
 
Figure 5.11. Concentration profiles of water, DMSO and BIC saturation levels (Ω = 
[BIC]total / [BIC]sat) at times of 0 ms, 1 ms, 10 ms and 100 ms after immersing a 
nanopipette containing aqueous electrolyte into DMSO (5 mM BIC and electrolyte). 
Nanopipette electrode bias of -0.3 V. 
 
The experimental data presented and discussed above, suggest a strong influence of 
the applied bias polarity on the crystallization process. Crystallization was only seen 
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in the case where a negative bias was applied to the nanopipette electrode. This 
behavior was explored further with FEM simulations. After a diffusional mixing time 
of 1 second, with an applied bias of -0.3 V to the nanopipette electrode, high relative 
saturation levels were observed throughout the tip, of up to Ω = 142 were observed a 
few microns up the length of the nanopipette (Figure 5.12 (a)). At these high saturation 
levels, nucleation and growth of BIC crystals is strongly favored, as mentioned above. 
In contrast, in the case where a positive bias was applied, Ω values above 1 were not 
seen, as shown in Figure 5.12 (b) and so crystallization would not be expected, as is 
the case experimentally under these conditions. Importantly, the solution was never 
supersaturated ( > 1) outside of the nanopipette domain, in either case, suggesting 
that any BIC particles must form inside the pipette. 
 
 
Figure 5.12. Predicted BIC saturation levels with a bias of -0.3 V (a) and +0.3 V (b) 
applied to the upper nanopipette boundary. Simulations were performed in 100 mM 
TBA+Cl- with 5 mM BIC in the DMSO phase initially. 
 
To accelerate the process, Figure 5.14 (a) shows an optical micrograph taken of a 
nanopipette after BIC growth experiments had been performed for ~10 min with 200 
mM BIC in the bath. It reveals solid products formed from these experiments inside 
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the tip. Crystals were also found to grow on the glass surface directly beneath where 
the probe was positioned for these growth experiments (Figure 5.14 (b)). The presence 
of these crystals outside the nanopipette is evidence that particles translocate the 
nanopipette orifice, and continue to grow and settle on the glass substrate beneath. 
Crystals were not observed in cases where a positive tip bias was applied to the 
electrode in the nanopipette.  
To confirm that the crystals formed were BIC, Raman Spectroscopy was employed, 
shown in Figure 5.14 (c). BIC has two polymorphs, represented in Figure 5.13. 
 
Figure 5.13. Single molecule diagrams of bicalutamide form I and II. 
 
Characterization of the resulting peaks for these samples lead to the conclusion that 
the formed crystals are of Form II BIC (comparing the data to Raman spectroscopy of 
reference compounds elsewhere).54 In particular, the strong peak at around 1600 cm-1 
is found in both BIC Forms, but the Form II crystal has π-π stacking interactions, which 
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causes an extra peak at 1582 cm-1, as highlighted in Figure 5.14 (c) that is not present 
in the spectrum of Form I. Form I is the more stable polymorph at all temperatures and 
Form II is labelled as the metastable state.55 Crystallization of BIC from bulk solutions 
at room temperature usually leads to Form I. Form II can be produced from the 
transformation of (solid-state) amorphous BIC at room temperature and this could be 
the route followed in this case, i.e. the high supersaturations that are attained at the end 
of the nanopipette (Figure 5.14 (a)) could promote crystallization of the amorphous 
form, with transition to Form II.55 A further consideration is that at the nanoscale, 
smaller crystals generally have higher free energies than larger ones, and the formation 
of the polymorph with the thermodynamically most stable bulk structure is not 
necessarily the one with the most stable surface structure.56-58 Crystal surface energy 
is significant for polymorph stability and the effect is further emphasized when the 
nature of the solvent is considered.33, 56  
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Figure 5.14. (a) Optical image of a typical nanopipette used in time-current 
measurements with 200 mM BIC in bath showing the formation of crystals inside the 
tip. (b) Additional formation of crystals in the bath containing 200 mM BIC after a 
nanopipette crystallization experiment. (c) Raman spectrum of BIC crystals formed, 
with main peak positions marked. The peaks highlighted at 1582 and 1600 cm-1 are 
most useful in resolving the BIC crystal type. 
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5.4. Conclusions  
In this study, it is shown that the nucleation and growth of BIC nanoparticles can be 
induced and monitored in real time using a simple nanopipette system. The approach 
advocated is an antisolvent/solvent approach in which crystallization is induced by the 
mixing of DMSO and water at the mouth of a nanopipette, with the applied bias 
providing control over the extent of crystallization. The bias applied can be used to 
promote or stop nucleation. Simultaneously, by measuring the current-time response 
at a given applied potentials current oscillations are observed which were attributed to, 
and shown to result from, the formation, and subsequent translocation, of BIC particles 
near the nanopipette orifice.  
With this simple approach, it is has been demonstrated that seeds can be produced that 
lead to the formation of Form II BIC at room temperature. To support the experiments, 
detailed FEM simulations have provided valuable information that help to validate the 
nucleation process, and provide estimates for the supersaturation levels achieved 
experimentally. In the future, with this unique, simple yet powerful nanoscale 
methodology, other APIs with polymorphic properties could be explored, as well as 
formulations of amorphous solid dispersions. There is also, the possibility of 
implementing this system for seed synthesis at larger scales, using multi porous 
membranes and designer potential-time profiles that promote nucleation and particle 
ejection. 
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5.5. Supporting Information  
5.5.1. Finite Element Method Simulations 
 In order to estimate the saturation levels of BIC that would be attained in nanopipette 
experiments, FEM simulations were performed with a 50 nm inner diameter 
nanopipette positioned in bulk solution. The concentrations applied inside and outside 
of the nanopipette are displayed in Figure 5.15 Ionic transport was assumed to follow 
the Nernst-Planck relationship, where the flux, Ji, of species, i, is given as: 
𝐽𝑖 =  −𝐷𝑖∆𝑐𝑖 − 𝑧𝑖
𝐹
𝑅𝑇
𝐷𝑖𝑐𝑖∇  (1) 
and the Poisson equation describes the electrical potential, :   
  
∇2 =  −
𝐹
𝜀𝜀0
 ∑ 𝑧𝑖𝑐𝑖𝑖                          (2) 
where ci denotes the species concentration, Di and 𝑧i denote the diffusion coefficient 
and charge number of the charge of species i and F, R, T,  and 0 specify constants: 
the Faraday constant, gas constant, temperature, relative permittivity and vacuum 
permittivity, respectively. The diffusion coefficients for water and DMSO were 
obtained from Table 5.2 and varied feely in the simulations according to the local 
liquid composition. The diffusion coefficient for BIC, as a function of solvent 
composition, was estimated from the local mole fraction of water and DMSO and the 
pure solvent diffusion coefficients, presented in Table 5.3, assuming a linear 
relationship between mole fraction and diffusion coefficient. BIC was initially 
considered to have a charge of zero when in the organic phase. The protonation of BIC 
in the aqueous phase was included in the simulations with the rate of formation of 
BICH+ from BIC given in equation 3. 
𝑅𝐵𝐼𝐶𝐻+ = 𝑘[𝐵𝐼𝐶][𝐻2𝑂] (3) 
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where k was set to be 10108 mol-1dm3s-1,  rapid compared to the diffusional mixing 
time, and [BIC] and [H2O] are the local concentrations of the deprotonated form of 
BIC and water respectively. OH- ions are formed at the same rate, with the neutral 
form of BIC removed (mass balance). 
Time-dependent simulations were performed allowing 1 second of mixing to give the 
saturation profiles presented in Figure 5.11. The saturation level,  was defined as: 
Ω =  
[BIC]𝑡𝑜𝑡𝑎𝑙
[BIC]𝑠𝑎𝑡
   (4) 
where [BIC]𝑡𝑜𝑡𝑎𝑙 includes protonation and neutral forms and [BIC]𝑠𝑎𝑡 was the value 
measured by UV-Vis spectroscopy.  
 
Figure 5.15. Schematic of FEM simulation domain with applied boundary conditions. 
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5.5.2. Diffusion Coefficients  
Table 5.2. Diffusion coefficients of H2O and DMSO in different compositions of DMSO 
and H2O,59 as used for FEM simulations 
 
 
 
 
Mole fraction 
H2O 
Diffusion coefficient (cm2/s) of 
H2O 
Diffusion coefficient (cm2/s) of 
DMSO 
0 0 8.50 ×10-6 
0.1 8.40 ×10-6 7.50 ×10-6 
0.2 8.00 ×10-6 7.20 ×10-6 
0.3 8.40 ×10-6 6.00 ×10-6 
0.4 8.30 ×10-6 5.30 ×10-6 
0.5 8.00 ×10-6 4.80 ×10-6 
0.6 7.00 ×10-6 4.00 ×10-6 
0.7 6.80 ×10-6 4.00 ×10-6 
0.8 1.00 ×10-5 5.30 ×10-6 
0.9 1.20 ×10-5 6.50 ×10-6 
1 2.60 ×10-5 0 
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Table 5.3. Calculated Diffusion coefficients of bicalutamide in H2O and DMSO using 
the Wilke Chang equation.60 
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Chapter 6  
Electrochemical oxidation of 
dihydronicotinamide adenine dinucleotide 
(NADH): Comparison of highly oriented 
pyrolytic graphite (HOPG) and polycrystalline 
boron-doped diamond (pBDD) electrodes 
_____________________________________ 
The electro-oxidation of nicotinamide adenine dinucleotide (NADH) is studied at bare 
surfaces of highly oriented pyrolytic graphite (HOPG) and semi-metallic polycrystalline 
boron-doped diamond (pBDD). A comparison of these two carbon electrode materials is 
interesting because they possess broadly similar densities of electronic states that are much 
lower than most metal electrodes, but graphite has carbon sp2-hybridization, while in 
diamond the carbon is sp3-hybridised, with resulting major differences in bulk structure and 
surface termination. Using cyclic voltammetry (CV), it is shown that NADH oxidation is facile 
at HOPG surfaces but the reaction products tend to strongly adsorb, which causes rapid 
deactivation of the electrode activity. This is an important factor that needs to be taken into 
account when assessing HOPG and its intrinsic activity. It is also shown that NADH itself 
adsorbs at HOPG, a fact that has not been recognized previously, but has implications for 
understanding the mechanism of the electro-oxidation process. Although pBDD was found to 
be less susceptible to surface fouling, pBDD is not immune to deterioration of the electrode 
response, and the reaction showed more sluggish kinetics on this electrode. Scanning 
electrochemical cell microscopy (SECCM) highlights a significant voltammetric variation in 
electroactivity between different crystal surface facets that are presented to solution with a 
pBDD electrode. The electroactivity of different grains correlates with the local dopant level, 
as visualized by field emission-scanning electron microscopy. SECCM measurements further 
prove that the basal plane of HOPG has high activity towards NADH electro-oxidation. This 
work is published in Physical Chemistry Chemical Physics. 
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6.1. Introduction  
Nicotinamide adenine dinucleotide (NADH) is an essential co-factor in various 
naturally occurring enzymatic reactions such as the oxidation of ethanol 
catalyzed by the enzyme alcohol dehydrogenase.1 NADH is the terminal 
electron donor in the mitochondrial electron transport chain. As such, the 
development of robust methods of analysis for NADH is of considerable 
importance, with electrochemical methods proving particularly effective. The 
mechanism of NADH oxidation has been studied extensively by Moiroux and 
Elving2-5 and it is well established that at neutral pH, NADH undergoes a two-
electron one-proton oxidation process of the ECE (electron transfer-chemical 
step-electron transfer) type: 
 
 
                                                                                               (1) 
                                                                                                
                                                                                               (2) 
 
                                                                                               (3) 
 
A wide range of carbon electrode materials have received considerable attention 
for NADH electro-oxidation, including glassy carbon,4,6 carbon paste,7 carbon 
nanotubes,8,9 graphene10 and graphene composites,11-13 pyrolytic graphite14 and 
boron-doped diamond.15 The study of NADH oxidation on bare carbon electrode 
surfaces is non-trivial.16 Relatively high overpotentials are often required and, 
furthermore, the oxidation products of NADH, particularly NAD+ tend to adsorb 
strongly and foul surfaces quickly.5,17, 18  
Electrode surface modification has been considered as a means of achieving an 
effective decrease in overpotential for NADH oxidation.19,20 However, studies 
of unmodified electrodes are valuable both to provide a benchmark and to seek 
the optimal electrode format. The electrochemistry of NADH at conducting 
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diamond has received attention, but the focus has mainly been on hydrogen-
terminated diamond,15, 21 with oxygen terminated diamond14 receiving only 
scant attention. Despite its importance as a well-defined model surface for sp2 
carbon, there are no reports of NADH oxidation at highly oriented pyrolytic 
graphite (HOPG) electrodes. It is important to note that the oxidation of NADH 
has been investigated at edge plane pyrolytic graphite (EPPG) and basal plane 
pyrolytic graphite (BPPG),14 but these materials should not be confused with 
HOPG. BPPG is a material with a much smaller crystallite size than HOPG, and 
hence has considerable edge plane character similar, in fact, to EPPG.22 
Comparison of electrochemical processes at HOPG and pBDD electrodes is 
interesting as they have broadly similar densities of electronic states (DOS) at 
the Fermi level over the typical range of potentials relevant for electrochemistry 
ca. (2−6) × 1020 cm−3 eV−1,23,24 that is about 1-2 orders of magnitude lower than 
metal electrodes. Yet, in other respects these materials may show different 
properties from each other. pBDD is sp3 hybridized and compared to other 
carbon electrodes, shows relatively high immunity to deactivation via fouling, 
long term stability and excellent reproducibility of voltammetry for many 
electrode reactions and repetitive voltammetric cycling.25 HOPG is an sp2 
carbon, the surface of which can readily be prepared and renewed via 
mechanical cleavage. It comprises of extensive basal terraces with a low density 
of point defects,26,27 and a step edge density that depends on the grade (quality) 
of the HOPG.28,29 Although early work considered the basal surface of HOPG 
to have ultra-low (or no) electrochemical activity,27,29-39 recent studies have 
highlighted the high activity of the basal surface for both simple redox reactions 
and more complex coupled electron-proton transfer processes.22,40,41 In the case 
of outer sphere redox processes, electron transfer rates are at least as fast at 
HOPG as on platinum.27  
The studies reported herein on the electrochemical oxidation of NADH at HOPG 
and oxygen-terminated pBDD reinforce, and amplify, the recent models on the 
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properties and activity of these electrode materials, while also providing detailed 
new insights on adsorption and surface fouling (contamination) processes. 
These measurements are complemented with high resolution scanning 
electrochemical cell microscopy (SECCM) 42,43 experiments to map the 
electrochemical activity of HOPG and pBDD and confirm the macroscopic 
findings. Making extensive use of macroscopic measurements at well-defined 
surfaces, for example, comparing the intrinsic activity of three different grades 
of HOPG that span step-edge density of more than 2 orders of magnitude.29, 41 
 
6.2. Experimental Section  
6.2.1. Materials and Solutions    
All chemicals were used as received. Aqueous solutions were prepared using 
high purity water (Purite, Select HP) with a resistivity of 18.2 MΩ cm at 25 °C. 
β-Nicotinamide adenine dinucleotide, reduced dipotassium salt hydrate 
(NADH, > 98 %), and phosphate buffer solution (pH 7.2) were purchased from 
Sigma-Aldrich. Sodium chloride (NaCl, 99.0 %, Sigma-Aldrich) was added to 
the phosphate buffer to give a phosphate buffer saline (PBS) solution. The 
working electrodes used in this study were a highly doped pBDD electrode, and 
HOPG electrodes of varying step edge densities. A 1 mm diameter pBDD disk 
electrode, used for macroscale electrochemistry was prepared in house from 
DIAFILM EA grade material (Element Six Ltd.).26,54 The average boron doping 
level of the pBDD material was ca. 5 × 1020 atoms cm−3, above the metallic 
threshold as confirmed by secondary ion mass spectrometry (SIMS).53 The 
pBDD had a roughness of 1-2 nm within a facet and 1-5 nm between grains, flat 
on the scale of SECCM and voltammetric measurements.51 Studies of basal 
plane HOPG employed one of three different grades: either ZYB or SPI-3 grade 
(SPI Supplies, West Chester, PA), or an ungraded HOPG sample of the highest 
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quality,30 originating from Dr. Arthur Moore at Union Carbide (now GE 
Advanced Ceramics), and kindly provided by Prof. R. L. McCreery of the 
University of Alberta, Canada, which is refer to throughout as “AM grade”). All 
HOPG samples were cleaved with Scotch tape to remove surface layers and 
reveal a fresh surface for study. This procedure has been shown to produce a 
very similar surface to mechanical cleavage.30 
6.2.2. Macroscale Electrochemistry  
Cyclic voltammetry (CV) was carried out in a three-electrode setup using a 
potentiostat (CH Instruments Model 750A, Austin, TX). A silver chloride coated 
Ag wire (Ag/AgCl) served as a quasi-reference electrode (QRE), while Pt gauze 
was used as the counter electrode. The Ag/AgCl QRE has a stable potential 
because AgCl has fast dissolution kinetics and it is sparingly soluble.44 All 
potentials are quoted against this QRE. The working electrodes (HOPG or 
pBDD) were as described above. On HOPG, a Teﬂon cell designed in house was 
used to provide a well-deﬁned 3 mm  diameter working cell; this has been 
described in detail in chapter 2.29 Because the BDD disk was encapsulated in 
glass, this could simply be immersed in solution, along with the other electrodes. 
Solutions contained different concentrations of NADH, as specified, in 0.1 M 
PBS. All solutions were prepared fresh on the day of the experiments and kept 
in the dark at all times when not in use. CV was performed at various potential 
scan rates (50, 100, 200, 400, 600 and 800 mV s-1) for the electro-oxidation of 
NADH at potentials between 0.0 and 1.0 V. CV measurements were made 
either: (1) as a series of different scan rates on an HOPG sample that was freshly 
cleaved before the series or (2) on a freshly cleaved surface for each scan rate. 
Making it clear when each protocol was used. The well-known scotch tape 
method was used to cleave HOPG.23,27-29,33,41,45-49 Similarly, the CV response of 
pBDD was measured either with or without polishing the electrode surface 
between each CV, and again state when each method was used. The pBDD 
electrode was polished with alumina particles (ca. 0.05 μm particle size, 
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Micropolish, Buehler, Germany) on a deionized water saturated polishing pad 
(Microcloth, Buehler, Germany) and then rinsed with deionized water to ensure 
the compete removal of alumina particles. 
6.2.3. Scanning Electrochemical Cell Microscopy 
High-resolution electrochemical imaging (SECCM) was performed on freshly 
cleaved HOPG (AM grade) and pBDD. The setup is shown schematically in 
Figure 6.1 and is described thoroughly elsewhere.43 In brief, a tapered dual-
channel borosilicate pipette, (with an opening diameter of ca. 400 nm for 
experiments on HOPG and ca. 1 µm for experiments on pBDD) was filled with 
electrolyte solution. Since the laser pipette pulling procedure produces two 
probes of closely similar dimension, the sister probe to that used for imaging 
was characterized with ﬁeld emission-scanning electron microscopy (FE-SEM), 
at 5 kV using a SUPRA 55 variable-pressure system (Zeiss). The probe used 
was ﬁlled with 1 mM NADH (for experiments on HOPG) and 0.5 mM NADH 
in 0.1 M PBS solution (for experiments on pBDD). A Ag/AgCl quasi-reference 
counter electrode (QRCE) was inserted in each channel. The SECCM 
instrument comprised of a high dynamics z-piezoelectric positioner (P-753.3CD 
LISA, Physik Instrumente), on which the pipette probe was mounted and an xy-
piezoelectric stage (P-622.2CL PIHera, Physik Instrumente) for sample 
mounting. Instrument control and data acquisition was achieved using an FPGA 
card (PCIe-7852R) with a LabVIEW 2011 interface (LabVIEW 9.0, National 
Instruments). A video camera (PL-B776U, Pixelink) with a ×2 magnification 
lens (44 mm, InfiniStix, Edmund Optics) was used to aid tip-positioning. 
A 200 mV bias, V1, was applied between the two QRCEs, giving rise to an ion 
conductance current (iDC) across the meniscus formed at the end of the pipette 
(see Figure 6.1). The tip was oscillated sinusoidally perpendicular to the surface, 
using the output generated by a lock-in ampliﬁer, at a frequency of 260 Hz, with 
a 20 nm peak-to-peak amplitude for the tip used for measurements on HOPG 
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and a 60 nm peak-to-peak amplitude for the tip used for pBDD measurements. 
The oscillation induced an alternating component of the ion conductance current 
(iAC) across the meniscus, when the meniscus was in contact with the substrate, 
and this was used as a set-point for feedback, to maintain a constant tip-to-
substrate separation during imaging.43 The currents, iAC and iDC, were measured 
simultaneously along with the electrode surface current (isub).  
The SECCM maps covered a 10 × 10 µm area of HOPG consisting of 32 line 
scans (16 forward and 16 reverse) at a tip scan rate of 0.3 µm s-1. Each line 
comprised of 12957 pixels, each pixel representing a current value that was the 
average of 256 readings. These measurements were made at a fixed working 
electrode of 0.5 V (low driving force, vide infra). For pBDD, voltammetric 
SECCM50 were employed in which the potential was swept between 0.0 and 0.8 
V, at 300 mV s-1 in which the theta pipette probe was approached to the surface 
until meniscus contact was made, as sensed by a change in iAC. At each pixel 
(point of meniscus contact) the working electrode potential was swept between 
0.0 V to 0.8 V (vs. Ag/AgCl QRCE) and the current-voltage response was 
recorded. Hopping scans on pBDD recorded (typically with a resolution of 40 × 
30 pixels) over an area of 60 × 45 µm and consisted of the following: a probe 
approach rate towards the surface of 0.3 µm s-1 to meniscus contact; potential 
sweep of 300 mV s-1 (potential swept between 0.0 and 0.8 V); 1.2 µm retraction 
distance at a rate of 5 µm s-1, enough to break the meniscus contact and move to 
the next position at a scan rate of 1.2 µm s-1. The distance between each hop 
(pixel) was chosen to be 1.5 µm, to avoid the overlap of adjacent probed areas. 
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Figure 6.1. Schematic of the SECCM setup in which a theta pipette was used to 
create a tiny meniscus electrochemical cell on a carbon electrode surface (HOPG or 
pBDD) with the working electrode size determined by the size of the pipette opening 
and meniscus wetting of the substrate. An ion conductance current (iDC) was 
generated by the potential bias, V1, between the two barrels of the pipette, while the 
voltage, V2, provided additional control of the potential of the working electrode. 
The resulting electrochemical current, isub, was measured to determine the local 
electroactivity. The conductance current has an AC component (see text for details), 
at the frequency of the pipette. 
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6.2.4. Atomic Force Microscopy  
AFM images of HOPG topography were recorded in air, using an Innova® AFM 
in tapping mode (AM and SPI-3 HOPG) and a BioScope Catalyst™ BioAFM 
in ScanAsyst mode (ZYB HOPG).  
6.3. Results and Discussion  
6.3.1. Voltammetry of NADH Oxidation on HOPG and pBDD 
Firstly, macroscale cyclic voltammetry (CV) measurements as a function of scan 
rate for ZYB grade HOPG and pBDD are considerd. For the detail in Figure 6.2 
(a) and (b), where j represents current density, an initial CV was run on either a 
freshly cleaved graphite surface, or polished pBDD, respectively, with no 
subsequent cleaning or cleaving before the subsequent voltammetric sweeps. In 
order to determine whether there was any electrode surface blocking, or other 
systematic effects, from the electrochemical process, as alluded to in the 
introduction, the first sweep was run at 50 mV s-1, followed by a set of 
subsequent sweeps at a series of increasingly faster scan rates (100, 200, 400, 
600 and 800 mV s-1). The first thing to note is the significant difference in the 
onset potential for the oxidation of NADH at the two different electrodes. On 
pBDD (Figure 6.2 (a)), the NADH oxidation peak occurred at a potential of ca. 
+0.55 V (at 50 mV s-1), which is in agreement with literature.15 As already noted, 
pBDD electrodes have high immunity to chemical fouling compared to other 
electrodes,25 and so fairly well-defined successive waves are observed. The 
oxidation peak potential shifts slightly with increasing scan rate to a more 
positive potential. In comparison, in Figure 6.2 (b), at HOPG, electro-oxidation 
is much more facile, occurring at a lower anodic potential with a value of ca. 
+0.40 V for the peak current (at 50 mV s-1). However, for CVs at increasing 
scan rates, the peak current does not increase as much at HOPG as might be 
expected, compared to the pBDD case, with the maximum peak current density 
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being only ca. 153 µA cm-2 at 800 mVs-1 (cf. 596 µA cm-2 at 800 mV s-1 for 
pBDD). Moreover, it can be seen that with increasing scan rates (number of 
scans), the voltammetric response becomes complex, with additional features 
appearing at more anodic potentials. This behavior, and its comparison to the 
pBDD response and the behavior on a surface freshly prepared before each 
voltammagram (discussed below), is strongly indicative of the HOPG surface 
becoming blocked by NADH oxidation products, as found for other carbon 
electrode materials.5, 14 
For comparison, CVs were run, for the same scan rates, at freshly polished 
pBDD or freshly cleaved HOPG prior to each CV. The results, shown in Figure 
6.2 (c) and (d), highlight similar voltammetric behavior at pBDD to the response 
in Figure 6.2 (a), in which the surface was not cleaned between each CV at each 
scan rate. For HOPG, the difference between Figure 6.2 (b) and Figure 6.2 (d) 
is stark. CVs on freshly cleaved surfaces showed well-defined peaks of much 
higher current density magnitude that scale reasonably with the square root of 
scan rate, as indicative of a diffusion-limited process. The positive shift in 
oxidation peak potential for the electrode process is mostly a consequence of the 
strong adsorption of NAD+ that is produced at the electrode during the oxidation 
of NADH. Although NAD+ may behave as a mediator of electron transfers from 
NADH to the electrode through the adsorbed layer, it inhibits the rate of the 
reaction.2 
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Figure 6.2. Oxidation of 1 mM NADH in 0.1 M PBS at various potential scan rates: 50, 
100, 200, 400, 600 and 800 mV s-1. For (a) pBDD and (b) ZYB the surface was cleaned 
or cleaved, respectively, prior to the first 50 mV s-1 scan, after which subsequent 
scans at increasing scan rates where run without further pretreatment or 
preparation of the electrode surface. For (c) pBDD* and (d) ZYB*, each voltammetric 
scan was made on a freshly polished pBDD or a freshly cleaved HOPG surface. The 
insets show plots of peak current vs. the square root of scan rate. 
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6.3.2. Repetitive Cyclic Voltammetric Response 
The extent to which the responses of the different carbon electrodes changed 
during NADH (1 mM) oxidation was studied by recording consecutive CVs (10 
runs at 100 mV s−1), with 5 s intervals between each CV, for each electrode. 
Figure 6.3 shows characteristic CVs for repetitive cycling using three grades of 
HOPG: (a) AM, (b) ZYB and (c) SPI-3, and (d) pBDD. 
The behavior of the three different grades of HOPG is closely similar for the initial 
scan, even though the step edge densities vary by more than 2 orders of magnitude,41 
as shown in Figure 6.4. This strongly suggests that for graphite the electrochemical 
response is mainly determined by the basal surface, not the step edges. In the case of 
pBDD,51-53 although recognized for combining high stability and resistance to 
chemical fouling, the repetitive cycling showed a decrease in current response over the 
10 cycles, but not to the same extent as HOPG. 
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Figure 6.3. Repetitive cyclic voltammograms for the oxidation of 1 mM NADH on (a) 
AM, (b) ZYB, (c) SPI-3 grade HOPG and (d) pBDD in 0.1 M PBS, at a potential sweep 
rate of 100 mV s-1. Each voltammogram was run with a 5 s interval between for a 
total of 10 cycles. 
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Figure 6.4. AFM topography images of freshly cleaved HOPG: (a) AM, (b) ZYB and (c) 
SPI-3 grades 
 
6.3.3. Adsorption Behavior of NADH on HOPG 
Although the studies herein indicate that the product of NADH adsorption, 
NAD+, adsorbs on both HOPG and pBDD, in line with studies on other 
electrodes,4,5 sought to elucidate whether NADH adsorbed. Early work 
suggested that NADH does not adsorb on pyrolytic graphite electrodes, although 
measurements were made at mM levels of NADH in bulk solution, and low to 
moderate voltammetry scan rates,4 where low levels of adsorption would be 
difficult to detect. For such studies HOPG was used, for which the background 
current is very low and decreased the concentration of NADH to 5 µM where 
the diffusional-electrochemical response would be greatly attenuated, compared 
to any signal for adsorbed material. CVs were run on freshly cleaved surfaces 
of AM, ZYB and SPI-3 HOPG at different scan rates (Figure 6.5 (a-c) (i)). 
Significant oxidative signals are seen that can be attributed to adsorbed NADH, 
and the lack of any reverse process indicates that this is an irreversible (anodic 
stripping) process.54 The data in Figure 6.5 (a-c) (ii) illustrate that the anodic 
peak current varies linearly with scan rate, as expected for electron-transfer to 
an adsorbed layer. Furthermore, the current density is noticeably greater on AM 
grade as compared to ZYB and SPI-3 HOPG. These latter grades of HOPG have 
higher step edge densities and have found in some other cases,27, 28 that this 
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appears to inhibit molecular adsorption. This suggests that the lateral interaction 
between adsorbed NADH is important, which is promoted on the extended basal 
surface of AM HOPG (Figure 6.4 (a)). This is also another explanation as to 
why NADH adsorption was not seen on pyrolytic graphite for which the step 
edge density is very high, along with the background (capacitive) currents 
during linear sweep voltammetry22 
 
To quantify amount of NADH adsorption, the area of the adsorbed voltammetric 
peaks was integrated to give the charge density, Q, for adsorbed NADH:  
 
𝑸 = 𝒏𝑭𝜞    (4) 
 
where n = 2 is the number of electrons involved in the redox reaction, and F is 
the Faraday constant, from which Γ, the surface concentration of NADH (mol 
cm-2) could be obtained. Plots of charge density versus scan rate (ν) for each 
HOPG grade  are given in Figure 6.5 (a-c) (iii) from which Γ values of 2.05 x 
10-11 mol cm-2 (AM grade), 1.03 x 10-11 mol cm-2 (ZYB) and 1.21 x 10-11 mol 
cm-2 (SPI-3) were obtained. Thus, the adsorption extent is rather small, but 
detectable, due to the low background currents at HOPG. 
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Figure 6.5. Oxidation of 5 µM NADH in 0.1 M PBS at various scan rates: 50, 100, 200, 
400, and 600 mV s-1 at (a) (i) AM (b) (i) ZYB and (c) (i) SPI-3. (a-c) (ii) Plots of current 
density (forward wave) against scan rate and (a-c) (iii) variation of forward peak 
charge with the log of scan rate for the 3 different HOPG grades.  
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6.3.4. High Resolution Imaging of Electrochemical Activity  
SECCM allows the measurement of surface electroactivity free from the 
topographical effects.55 As highlighted above, the process of NADH oxidation 
can lead to the rapid deterioration of the electrode surface activity, which means 
that conventional electrochemical imaging techniques, where the whole 
electrode surface would be immersed in solution and carrying out this reaction 
- as in the case for scanning electrochemical microscopy (SECM)32 -  would be 
of limited use. The advantage of SECCM is that only a small fraction of the 
surface at a time is in contact with the electrolyte solution during a scan. 
Moreover, by judicious selection of the local meniscus contact time, 
measurements can be made on a close to pristine surface, before surface 
blocking occurs, and blocking products can be left behind as the probe meniscus 
moves to a new location on the surface.56 
Firstly, SECCM measurements were perfomed on HOPG (AM grade). Two 
successive CVs with 1 mM NADH on AM grade HOPG at 100 mV s-1 with a 
meniscus contact diameter of 400 nm are shown in Figure 6.6 (a). A large 
hysteresis between the forward and reverse waves is observed. On this CV time 
scale, which has a relatively high mass transfer coefficient, similar to a disk 
electrode of about 10 times the contact diameter (i.e. 4 µm), a sigmoidal 
response would have been expected for a simple electrochemical reaction, with 
the forward and reverse waves closely similar.57 The observation can be 
attributed to a blocking of the electrode. Additionally, the peak in the first 
forward wave decreases in the second scan, also indicating blocking of the 
electrode by reaction products. SECCM mapping of surface electrochemistry 
was carried out with 1 mM NADH in 0.1 M PBS at a potential of 0.5 V (Figure 
6.6 (a)), in order to not fully drive the oxidation reaction and minimize blocking, 
with a lateral probe scan rate of 0.3 µm s-1. The residence time was about 1 s 
and based on the measured currents of ca. 4 pA, about 107 molecules were turned 
over at the surface in contact with the meniscus cell. Figure 6.6 (b), the SECCM 
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electrochemical activity map of HOPG, reveals fairly uniform activity across 
the surface, with current values similar to those in the initial values. Additonally, 
Figure 6.6 (c) shows uniform conductance current between the QRCEs in the 
barrels of the SECCM tip, indicating very stable mensicus contact and surface 
wetting, during imaging. From these maps we can readily conclude that the 
electrochemical reaction occurs easily at the basal surface of HOPG. 
 
Figure 6.6. (a) SECCM CVs for the oxidation of 1 mM NADH in 0.1 M PBS at 100 
mV s-1. SECCM maps of (b) surface electrochemical activity and (c) 
conductance current (DC component) recorded at the half-wave potential for 
the oxidation of 1 mM NADH at HOPG (AM), obtained with a ca. 400 nm 
diameter pipette. 
Chapter 6 
166 
 
Next, pBDD electrode was considered. Figure 6.7 (a) (i) and (iii) show an optical 
image of the SECCM probe and electrode before and after an image. Using the 
in-rig camera, the area where the image was made is marked by the deposition 
of material. As mentioned in the experimental section, these measurements were 
run in a hopping-voltammetry mode (300 mV s-1). This was possible because 
the extent of blocking of pBDD by NADH oxidation products is less extensive, 
although still occurs, as the positions where measurements were made were 
clearly revealed using FE-SEM by spot deposits left behind (Figure 6.7 (a) (ii)). 
These spots are fairly consistent and approximate to the tip size (Figure 6.7 (a) 
(iv)). After cleaning the pBDD surface, with FE-SEM the area in which an 
SECCM image was recorded was visualized. (Figure 6.7 (b) (i)). Previous FE-
SEM studies confirmed that lighter and darker areas correspond to less-doped 
(more charging) and more-doped (less charging) facets respectively.56,58 
Potential-resolved snap shots of electrochemical activity, from a series of 
images, at potentials of 0.5 V, 0.6 V and 0.7 V are shown in Figure 6.7 (b) (ii-
iv). Close to the onset of the oxidation current (0.5 V), we begin to see the 
appearance of the more-doped facets on the electrochemical image, and as the 
working electrode potential is scanned positive, there is an increase in surface 
current, but particularly so in the more doped facets. Thus, for pBDD, the 
variation in the dopant level appear to have a significant impact on local 
electrochemical activity, as seen for a range of other reaction.24,56 This needs to 
be taken into account to understand the electrochemical properties of this 
material and particularly in the analysis of macroscopic and voltammetric data. 
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Figure 6.7. (a) (i) Optical microscope image of the pBDD substrate, taken using the 
in-rig camera before performing the SECCM map and (ii) after scan. (iii) FE-SEM 
micrograph of the scanned area, covered by spots of reaction products formed 
during each local voltammetric scan. (iv) FE-SEM micrograph showing a zoom of 
typical spots after hopping voltammetric mode SECCM imaging. (b) (i) FE-SEM image 
of the same area of pBDD after cleaning to remove the adsorbed material. (ii-iv) Snap 
shot SECCM electrochemical maps (60 µm × 45 µm) at different potentials, as 
marked above each map.  
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6.4. Conclusions 
The voltammetric response of NADH at freshly cleaved HOPG and oxygen-
terminated pBDD has been analyzed in detail at the macroscale using high-
resolution electrochemical imaging. These two materials have relatively similar 
DOS, yet the electro-oxidation of NADH is much faster on the basal plane of 
HOPG than on pBDD. On the other hand, the electrochemical oxidation of 
NADH is a redox process complicated by side reactions. Oxidation products 
tend to adsorb onto the surface and as manifest in a deterioration of the 
electrochemical response, with this process occurring more extensively on 
HOPG than on pBDD. These effects need to be recognized and accounted for 
when considering the intrinsic behavior of these electrode materials. 
The observations reported herein demonstrate that the electro-oxidation of 
NADH is facile at the basal plane of HOPG and independent of step edge 
density, as is the deterioration of the electrode response due to blocking by 
reaction products. The high intrinsic activity of the basal plane HOPG for these 
reactions has been demonstrated unequivocally using high resolution 
electrochemical imaging. An important new feature to NADH oxidation at sp2 
carbon electrodes revealed by this work is a contribution to the electrochemical 
response from adsorbed NADH, providing a further illustration of the potential 
importance of adsorbed reactants in electrochemistry at HOPG. The extent of 
adsorption (as inferred from the electrochemical signal) is enhanced at the 
highest quality (low step edge density) HOPG, i.e. is promoted by extensive 
basal surface regions. 
In contrast to HOPG, electrochemical currents for NADH oxidation at pBDD 
electrodes are strongly correlated with the local boron dopant concentration in 
individual facets. This is an important issue that must be taken into account in 
order to gain a holistic view of pBDD electrochemical characteristics. 
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Chapter 7  
Conclusions 
_____________________________________ 
Fundamental understanding of the kinetics and mechanisms of dissolution and growth 
are very beneficial in the pharmaceutical science. Despite their importance and many 
years of research, the general processes governing dissolution and crystallization of 
crystals at the nanoscale need to be better understood, particularly for pharmaceutical 
crystals and other molecules. Thus, innovative approaches are highly desired. A major 
new aspect of the work in this thesis is the application of multi-microscopy systems 
and techniques to gain a holistic overview and understanding of dissolution and growth 
of pharmaceutics. The combined use of a range of scanning probe microscopy and 
spectroscopy techniques, as well as complementary FEM simulations, have provided 
new insight into API dissolution and growth behaviour. Such methodologies allowed 
the study of dissolution from single crystal faces, from targeted regions of a crystal 
face/amorphous surface, and visualisation of the reactivity of whole crystals in real 
time.  
Drugs with poor aqueous solubility demonstrate low oral bioavailability, which is a 
major challenge to pharmaceutical scientists. This has been one of the most critical 
issues in pharmaceutical industry for many years and, thus, chapter 3 focused on 
fundamental understanding of API dissolution, with a study of bicalutamide, as an 
exemplar. The combined use of AFM and FEM allowed the surface processes which 
accompany dissolution to be monitored in real time and dissolution kinetics to be 
obtained. Morphological changes and formation of pits associated with surface 
controlled dissolution were observed. AFM data were used to parameterise FEM 
model simulations of a dissolving BIC microcrystal to provide direct concentration 
distributions around and at individual crystal faces. As a result, determining the 
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importance of surface kinetic compared to mass transport for each crystal face was 
possible. Importantly, all BIC crystal faces showed surface kinetic controlled 
dissolution behaviour, being far from mass transport limited regime. However, the 
degree of mixed control changed dramatically during the process. This work has 
shown that, generally, the use of a single microcrystal drug can give a big insight in 
understanding drug dissolution kinetics and thus assist in the pharmaceutical 
formulation development of poorly soluble drugs.  
One of the most significant approaches to enhance dissolution rates and achieve higher 
apparent solubility of drugs is the development of ASDs. In view of that, Chapter 4 
uniquely demonstrated the use of a multi-microscopy approach to locally probe the 
aqueous dissolution process of ASD comprising of felodipine API and copovidone 
polymer in real time. It presented the use of a droplet-based electrochemical technique, 
a methodology that was previously shown to reveal considerable quantitative 
information on various surfaces and interfacial processes. Quad-probes made of quartz 
nanopipettes were used to monitor dissolution of two different formulations, one 
containing 15% w/w felodipine and the other of higher API dosage of 50% w/w. The 
droplet cell incorporating two working electrodes enabled localized dissolution flux 
measurements. A much-enhanced current response, for the detection of dissolving 
felodipine was observed for the 15 % drug loaded dispersion compared to the 50 % 
dispersion as dissolution initiated. These studies were complemented with in situ AFM 
and Raman spectroscopy that enabled mechanistic and kinetic insights on changes in 
the solid-state material during ASD dissolution. With Raman spectroscopy, the 
dissolution was monitored of both the API and polymer simultaneously. For the 50 % 
drug loaded dispersion, recrystallization of felodipine was observed. This was further 
proved by AFM studies, where change in topography was tracked over time and 
formation of particles on the surface was observed. In contrast, the Raman spectra 
recorded for the 15 % drug loaded dispersion did not show any significant changes 
during dissolution. This indicates that felodipine and copovidone dissolve as a single 
entity. Such observations and those seen at the nanoscale agreed well with other 
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findings emphasizing the importance of drug/polymer ratio in ASD formulations, 
where they influence the overall dissolution mechanism. Consequently, with this 
multi-microscopy approach, other ASD formulations of different API/polymer content 
could be investigated to further improve the understanding of ASD performance in 
vivo.    
Focusing on the applications of nanopipette-based methods, chapter 5 demonstrated 
the use of nanopipettes as nanoreactors to study the crystallization of BIC in an 
antisolvent configuration (BIC in DMSO, mixed at the nanoscale with water). Voltage-
controlled ion migration was used to mix two different solutions to induce 
crystallization at the nanopore interface generating oscillating current blockades. The 
frequency of these events and the extent of tip blockage was shown to be altered by 
variation in the potential bias and concentration of BIC in the bath. Monitoring 
crystallization in real time at the nanoscale provided unique information about the 
nucleation process, and indeed the analysis of formed crystals with Raman 
spectroscopy showed the formation of the metastable Form II BIC. Thus, the use of 
nanopipettes provides a simple, but powerful, way to form organic crystals of different 
polymorphs. Additionally, with this simple growth methodology one can examine the 
effect additives have on growth/dissolution rates.     
Finally, Chapter 6, shows the robustness, unique capabilities and advantages of a 
droplet based technique showing the implementation of SECCM on other complex 
systems. Herein, SECCM was used in the study of NADH oxidation at bare surfaces 
of HOPG and pBDD; two carbon electrode materials possessing broadly similar 
densities of electronic states, but radically differ in sp hybridization and surface 
termination, and hence 3D structure.  We have shown that the electrochemical 
oxidation of NADH is indeed a complex redox process and its oxidation is very much 
related to the history of the electrode surface used. Results showed unequivocally that 
the pristine HOPG surface, which has been previously described as supporting only 
sluggish electron transfer behaviour, or even as being completely inert has, in fact, 
considerable activity. Additionally, with SECCM it was possible to map grain 
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boundaries of pBDD and unambiguously observe no enhancement in activity for the 
oxidation of NADH compared to the grain surface. Due to SECCM’s ability of 
obtaining localized droplet electrochemical measurements of which droplet size 
depends on the dimensions of the nanopipette, these novel observations of such 
complex system were made possible.   
Overall, I hope that this thesis has given a unique scope on the use of microscopy and 
electrochemical techniques to study dissolution and growth of APIs. Introducing such 
methodologies, particularly nanopipettes, into the pharmaceutical domain can 
certainly lead to exciting new findings that can help to elucidate fundamental 
processes. The last results chapter further shows that the methods developed have 
wider application. 
 
